<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Dmt7109</id>
		<title>Media Wiki - User contributions [en]</title>
		<link rel="self" type="application/atom+xml" href="http://ifi-wikis.com/IFI-OpioidCrisis/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Dmt7109"/>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/Special:Contributions/Dmt7109"/>
		<updated>2026-08-08T07:10:39Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.30.1</generator>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Treatment_and_Recovery_Support_During_Incarceration&amp;diff=19907</id>
		<title>Enhance Treatment and Recovery Support During Incarceration</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Treatment_and_Recovery_Support_During_Incarceration&amp;diff=19907"/>
				<updated>2020-04-08T00:13:08Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users|Zoom Map - (Shift from Punishment to Treatment Approach for Opioid Users)]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Overview =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research has shown that a vast amount of the inmate population, on both the state and federal level, suffer from substance use disorder, a psychological disorder, or a combination of the two. Studies have shown that proper treatment during incarceration that is followed through to post release, significantly lowers their risk for relapse, criminality, inmate misconduct, and recidivism.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Prison Treatment Programs =&lt;br /&gt;
&lt;br /&gt;
The Criminal Justice System has supported treatment during incarceration by offering&amp;amp;nbsp;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;psychotherapy sessions, religious ministry meetings and 12-step programs such as Alcoholics Anonymous to inmates with substance use problems.&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
While there is significant need for more availability, federal prisons offer a number of programs designed to assist inmates in overcominig a substance use disorder such as:&lt;br /&gt;
&lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Drug Abuse Education&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**E&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ntails a series of classes that educate inmates on substance use disorder and the effects it has on your body and mind&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Nonresidential Drug Abuse Treatment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**A&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;12 week CBT (cognitive-behavioral therapy) program that is organized in group sessions&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;This program addresses criminal lifestyles while also giving inmates the opportunity to increase skills in the areas of rational thinking, communication, and institution to community adjustment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Inmates that are enrolled in this program normally have short sentences, do not meet the Residential Drug Abuse Program, are waiting to be enrolled in RDAP, are in transition back into the community or have a positive urinalysis test&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref&amp;gt;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;lt;/ref&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Residential Drug Abuse Program (RDAP)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**T&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;he most intensive program that the Bureau provides&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Inmates in this program live in their own separate community from the rest of the population. Inmates take part in daily half-day programming and half-day of work, school, or vocational activities; this program is normally nine months in length&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research shows inmates that take part in RDAP are less likely to recidivate and relapse to drug use by significant amounts compared to those inmates who do not take part in RDAP&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref&amp;gt;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;lt;/ref&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Community Treatment Services (CTS)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Provides continued care to inmates who have been released and put into Residential Reentry Centers or on Home Confinement&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Evidence shows that the period after being released is the most vulnerable time for inmates to relapse back to drug use or criminal activity; continued treatment after release is vital to the success of the offender completing their treatment&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref&amp;gt;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;lt;/ref&amp;gt;   &lt;br /&gt;
&lt;br /&gt;
= Benefits of Successful Prison Treatment Programs =&lt;br /&gt;
&amp;lt;div&amp;gt;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Well-designed prison treatment programs reduce relapse, criminality, inmate misconduct and recidivism — the likelihood that a convicted criminal will reoffend. They also increase levels of education, mend relationships, boost employment opportunities upon release and improve overall health.&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://doi.org/10.1007/s11920-013-0414-z&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research shows that residential prison treatment is cost-effective if prisoners continue treatment after their release. The cost of treatment pales in comparison to the cost of incarceration. Rehab helps prisoners overcome drug use and reduces the economic burden of recidivism.&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref&amp;gt;https://doi.org/10.1007/s11920-013-0414-z&amp;lt;/ref&amp;gt;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Issues Affecting the Availability of Effective Treatment =&lt;br /&gt;
&lt;br /&gt;
== Overcrowding of Jails and Prisons ==&lt;br /&gt;
&lt;br /&gt;
O&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;vercrowding of jails and prisons is a leading factor as to why inmates with drug dependency problems are not enrolled in these programs. The overcrowding of jails leads to an increase in the length of the waiting lists to enter drug treatment programs. In addition to overcrowding, staff shortages and limited resources are part of the issue of low enrollment in drug treatment programs.&amp;lt;ref&amp;gt;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Need for Trauma-Informed Care ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Incarcerated prisoners are marked by considerable diversity, yet they share a common experience of incarceration. Prisons can be violent, harsh, psychologically damaging environments; incarcerated people live in an environment that is both depersonalizing and dehumanizing. Moreover, the social stigma associated with incarceration, combined with the depersonalizing effects of imprisonment, may result in a sense of hopelessness and powerlessness, as well as deeply internalized shame and guilt. Thus, in addition to treating substance abuse and other mental disorders, the consensus panel recommends that in-prison treatment also address the trauma of the incarceration itself as well as a prison culture that conflicts with treatment goals.&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/books/NBK64123/&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Training =&lt;br /&gt;
&lt;br /&gt;
 Residential Substance Abuse Training RSAT training and technical assistance tool&lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Treatment_During_Incarceration|TR - Enhance Treatment During Incarceration]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Community_Service_Alternatives_to_Incarceration&amp;diff=19906</id>
		<title>Expand Community Service Alternatives to Incarceration</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Community_Service_Alternatives_to_Incarceration&amp;diff=19906"/>
				<updated>2020-04-08T00:11:29Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;Return to [[ZOOM_MAP_-_Prioritize_SUD_Treatment_Over_Incarceration|Zoom Map - Prioritize SUD Treatment Over Incarceration]] &lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
When people are breaking laws, get arrested and convicted of a crime, having their punishment be in the form of community service can be an alternative to incarceration.&amp;amp;nbsp; This can be less damaging to their lives moving forward than incarceration.&amp;amp;nbsp; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Alternative to incarceration is any punishment given to an individual who commits a crime that is served by means outside of confinement in a jail or prison. Alternatives to incarceration have proved to be less expensive than incarceration. Additionally, alternatives can repair harms suffered by victims, provide benefits to the community, treat individuals struggling with SUD, mental illness, or a coexistence of both; and rehabilitate offenders. It is important that before we can maximize the benefits of alternatives to incarceration, however, we must repeal mandatory minimums and give courts the power to use cost-effective, recidivism-reducing sentencing options instead.&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Pros of Alternatives to Incarceration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Give Courts More Sentencing Options&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Each offender and crime is unique, and prison or jail time may not always be the most effective response. If courts have options other than incarceration, they can better tailor a cost-effective sentence that fits the offender and the crime, protects the public, and provides rehabilitation.&amp;lt;ref&amp;gt;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;&amp;lt;u&amp;gt;'''Save Taxpayer Money'''&amp;lt;/u&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;It costs over $28,000 to keep one person in federal prison for one year (some states’ prison costs are much higher).&amp;amp;nbsp; Alternatives to incarceration are cheaper, help prevent prison and jail overcrowding, and save taxpayers millions.&amp;lt;/font&amp;gt;&amp;lt;ref&amp;gt;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''S'''&amp;lt;/u&amp;gt;&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;&amp;lt;u&amp;gt;'''trengthen Families and Communities'''&amp;lt;/u&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Prison or jail time separates the offender from his or her spouse and children, sometimes for decades at a time. Alternatives to incarceration keep people with their families, in their neighborhoods and jobs, and allow them to earn money, pay taxes, and contribute to their communities.&amp;lt;/font&amp;gt;&amp;lt;ref&amp;gt;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;u&amp;gt;P&amp;lt;/u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;'''&amp;lt;u&amp;gt;rotect the Public by Reducing Crime&amp;lt;/u&amp;gt;'''&amp;amp;nbsp;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Over 40% of all people leaving prison will reoffend and be back in prison within three years of their release. Alternatives to prison such as drug and mental health courts are proven to confront the underlying causes of crime (i.e., drug addiction and mental illness) and help prevent offenders from committing new crimes.&amp;lt;/font&amp;gt;&amp;lt;ref&amp;gt;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;&amp;lt;u&amp;gt;'''The Public Supports Alternatives to Incarceration'''&amp;lt;/u&amp;gt;&amp;amp;nbsp;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Over ~75% of adults believe that alternatives to incarceration (probation, restitution, community service, and/or rehabilitative services) are the most appropriate sentence for nonviolent, non-serious offenders and that prison or jail are appropriate only if these alternatives fail.&amp;lt;/font&amp;gt;&amp;lt;ref&amp;gt;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Incarceration Alternatives =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Some argue that alternative to incarceration is a lesser sentence without impact. But studies have shown that the vast majority of survivors also prefer investments in education, mental health treatment, drug treatment, and job training to more spending on prisons and jails.&amp;lt;ref&amp;gt;https://www.nidirect.gov.uk/articles/non-custodial-sentences&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Various Alternative Sentences as Alternative to Incarceration&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Monetary Fine&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;A fine is the most common form of punishment given by the courts. The offender must pay a fixed sum of money. If they don't pay, they could get a prison sentence.&amp;lt;/font&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Probation Order&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*W&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;hen an offender is supervised by a probation officer in the community for a certain time.Sometimes the court will apply additional requirements to the probation order, including:&amp;lt;/font&amp;gt; &lt;br /&gt;
**&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Mandatory attendance of a alcohol or drug rehabilitation center&amp;lt;/font&amp;gt; &lt;br /&gt;
**&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Mandatory attendance of a day center&amp;lt;/font&amp;gt; &lt;br /&gt;
**&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Mandatory attendance of any other medical treatment or counselling&amp;lt;/font&amp;gt;   &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Community Service Order&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;When an offender gets a community service order, they must do unpaid work in the community for a derration that is decided in the discretion of the judge&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;They must work the hours as instructed. If they don't do the work, they will be returned to court, where they could receive a fine or any other sentence&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;This can be utilized in combination with a probation order&amp;lt;/font&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Conditional or Absolute Discharge&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Expand_Community_Service_Alternatives_to_Incarceration|TR - Expand Community Service Alternatives to Incarceration]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Law_Enforcement_Assisted_Diversion_and_Deflection_Programs&amp;diff=19904</id>
		<title>Expand Law Enforcement Assisted Diversion and Deflection Programs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Law_Enforcement_Assisted_Diversion_and_Deflection_Programs&amp;diff=19904"/>
				<updated>2020-04-08T00:07:46Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;''Return to [[ZOOM_MAP_-_Prioritize_SUD_Treatment_Over_Incarceration|Zoom Map - Prioritize SUD Treatment Over Incarceration]]&amp;amp;nbsp;'' &lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
The most common phrase you will hear from law enforcement leadership across the country is, “We recognize we cannot arrest our way out of this problem.” We must provide our first responders and criminal justice system with the tools, resources, and support to ensure those fighting substance use disorder receive treatment and those profiting from their addiction and tragic deaths face harsh justice.&amp;amp;nbsp;Whether in the aftermath of an opioid overdose reversal or while transitioning in and out of incarceration, those battling addiction must be presented with the opportunity for treatment so they can begin their road to recovery.&lt;br /&gt;
&lt;br /&gt;
= Strengths of Pre-Arrest Diversion =&lt;br /&gt;
&amp;lt;div&amp;gt;Pre-arrest Diversion programs&amp;amp;nbsp; provide law enforcement with an alternative to having to make arrests. Instead, as long as a person meets certain criteria, they can avoid a police record, stay out of the criminal justice system, and modify future behavior, all the while attempting to also uncrowd U.S. correctional facilities.&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot; style=&amp;quot;color: rgb(51, 51, 51); font-family: sans-serif,arial,verdana,&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Goal of Pre-Arrest Diversion =&lt;br /&gt;
&amp;lt;div&amp;gt;&lt;br /&gt;
Depending on local community needs and behavioral health capacity, police diversion programs across the country have varying designs, but their goals are consistent:&lt;br /&gt;
&lt;br /&gt;
*To continue to promote and enhance public safety while also responding more effectively to substance use and mental health problems &amp;lt;ref&amp;gt;http://www2.centerforhealthan djustice.org/content/project/police-deflection&amp;lt;/ref&amp;gt; &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:10.5pt;font-family:arial;color:#323232;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;&amp;quot;&amp;gt;To low-level offenses, pre- arrest diversion helps to reverse the tide of people with nonviolent offenses entering the justice system&amp;lt;/span&amp;gt;'''&amp;lt;ref&amp;gt;http://www2.centerforhealthan djustice.org/content/project/police-deflection&amp;lt;/ref&amp;gt; &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
= Pre-Arrest Diversion Frameworks =&lt;br /&gt;
&amp;lt;div&amp;gt;&lt;br /&gt;
The variety of operational characteristics of pre-arrest diversion programs creates nearly unlimited possibilities for the final program design, some common themes can be observed in deflection programs currently operating.&amp;lt;ref&amp;gt;http://www2.centerforhealthandjustice.org/sites/www2.centerforhealthandjustice.org/files/publications/DeflectionFramework-excerpt_Final.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Naloxone Plus: Engagement with treatment occurs following&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'and overdose response and crisis-level treatment is readily available. Examples: opiate response teams, STEER (MD)&amp;amp;nbsp;'&amp;lt;ref&amp;gt;http://www2.centerforhealthandjustice.org/sites/www2.centerforhealthandjustice.org/files/publications/DeflectionFramework-excerpt_Final.pdf&amp;lt;/ref&amp;gt; &amp;amp;nbsp; Active Outreach: Participants are identified by law enforcement, but are engaged primarily by a treatment expert who actively contacts them and motivates them to engage in treatment. Example: Arlington Model (MA)&amp;amp;nbsp;&amp;amp;nbsp;'&amp;lt;ref&amp;gt;http://www2.centerforhealthandjustice.org/sites/www2.centerforhealthandjustice.org/files/publications/DeflectionFramework-excerpt_Final.pdf&amp;lt;/ref&amp;gt;&amp;amp;nbsp; Self-Referral: Drug-involved individuals initiate engagement with law enforcement without fear of arrest, and an immediate treatment referral is made. Example: Angel (MA)&amp;amp;nbsp;&amp;amp;nbsp;'&amp;lt;ref&amp;gt;http://www2.centerforhealthandjustice.org/sites/www2.centerforhealthandjustice.org/files/publications/DeflectionFramework-excerpt_Final.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;Officer Prevention Referral&amp;lt;/u&amp;gt;: Law enforcement initiates the treatment engagement, but no charges are filed. Examples: LEAD (WA), STEER (MD)''''&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255); color: rgb(50, 50, 50); font-family: arial; font-size: 10.5pt; font-style: normal; font-variant: normal; font-weight: 400; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;&amp;quot;&amp;gt;&amp;lt;ref&amp;gt;http://www2.centerforhealthandjustice.org/sites/www2.centerforhealthandjustice.org/files/publications/DeflectionFramework-excerpt_Final.pdf&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;u&amp;gt;Officer Intervention Referral&amp;lt;/u&amp;gt;: Law enforcement initiates the treatment engagement, and charges are held in abeyance or citations issued. Examples: Civil Citation (FL), STEER (MD)”'&amp;lt;ref&amp;gt;http://www2.centerforhealthandjustice.org/sites/www2.centerforhealthandjustice.org/files/publications/DeflectionFramework-excerpt_Final.pdf&amp;lt;/ref&amp;gt;'&amp;lt;/div&amp;gt; &lt;br /&gt;
= LEAD Program =&lt;br /&gt;
&amp;lt;div&amp;gt;LEAD is a pre-booking diversion program that allows officers to redirect low-level offenders engaged in drugs or prostitution activity to community-based services instead of jail and prosecution. LEAD participants begin working immediately with case managers to access services.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;According to a 2015 report by the International Centre for the Prevention of Crime (ICPC), &amp;quot;One of the [ONDCP] strategy's objectives for 2015 is to break the cycle of drug use, crime, delinquency, and incarceration by increasing by 5% the number of residential juvenile justice facilities offering substance abuse treatment, and increasing by 2.6% the number of treatment plans completed by individuals referred by the Criminal Justice System (ONDCP, 2012, p.18).&amp;quot;&amp;lt;ref&amp;gt;https://www.unodc.org/documents/ungass2016/Contributions/Civil/ICPC/Rapport_FINAL_ENG_2015.pdf&amp;lt;/ref&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot;&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Other Programs =&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;u&amp;gt;The S.M.A.R.T. Approach&amp;lt;/u&amp;gt; ==&lt;br /&gt;
SMART supports chronic misdemeanor offenders, particularly those who are otherwise resistant to intervention, with a case manager and offers individualized treatment and tailored housing placements. SMART prioritizes chronic misdemeanor offenders with acute drug addictions and complex social service needs.&amp;lt;br/&amp;gt; See fact sheet here: &amp;lt;div&amp;gt;[[File/view/SMART_Fact_Sheet.pdf/623773107/SMART_Fact_Sheet.pdf|[File:http://www.wikispaces.com/i/mime/32/application/pdf.png SMART Fact Sheet.pdf]]] &amp;lt;div&amp;gt;[[File/view/SMART_Fact_Sheet.pdf/623773107/SMART_Fact_Sheet.pdf|SMART Fact Sheet.pdf]]&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
== &amp;lt;u&amp;gt;STEER&amp;lt;/u&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
STEER is a police deflection initiative that incorporates prevention deflection and intervention deflection. The priority is to improve public safety by police and human services working together. It operates around the core value proposition of deflection, namely ensuring the proper placement of citizens either into the criminal justice system or away from it and towards the human services system. This results in reducing crime, building community relations, reducing drug use, and restoring the lives of citizens. STEER deflection provides a natural strategy to improve community relations by showing citizens the police know when a citizen needs help inistead of needing to be arrested. STEER makes clear that the police are indeed here to help and not just to arrest.&amp;lt;ref&amp;gt;http://www2.centerforhealthandjustice.org/sites/www2.centerforhealthandjustice.org/files/publications/STEER-FactSheet.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;u&amp;gt;DTAP - Drug Treatment Alternative To Prison&amp;lt;/u&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
This program had a high rate of success.&amp;amp;nbsp; See this [https://www.centeronaddiction.org/addiction-research/reports/crossing-bridge-evaluation-drug-treatment-alternative-prison-dtap-program evaluation report] from 2003 for impressive statistics.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Expand_Law_Enforcement_Assisted_Diversion_Programs|TR - Expand Law Enforcement Assisted Diversion Programs]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]] [[Category:SAFE-Treatment and Recovery]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_Screening_for_Infectious_Disease_among_Those_with_SUDs&amp;diff=19903</id>
		<title>Improve Screening for Infectious Disease among Those with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_Screening_for_Infectious_Disease_among_Those_with_SUDs&amp;diff=19903"/>
				<updated>2020-04-08T00:04:54Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;__NOTOC__Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]] &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;__TOC__ &lt;br /&gt;
= Current Status =&lt;br /&gt;
&lt;br /&gt;
*Hep C virus (HCV) infections tripled between 2010 and 2015 &lt;br /&gt;
*Substance abuse and infectious diseases shared common populations, risk factors, social determinants, and even contracting venues&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[1]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*There was little collaboration between programs that provided services to these populations&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[2]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*Methadone clinics would be optimal venues for service integration because these clinics serve a population that is 60% injection drug users; have medical staff performing brief health assessments for all new clients; and already have some infectious disease screenings in place, including routine tuberculosis testing and intermittent opt-in HIV testing&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[3]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*One study showed that 68% of opioid treatment programs nationwide had staff capacity for HCV testing, but only 33% actually offered on-site HCV testing&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[4]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #333333; font-family: roboto,'helvetica neue',helvetica,arial,sans-serif; font-size: 16px&amp;quot;&amp;gt;Awareness of HCV infection among this particular population may motivate them to reduce their consumption and hopefully high-risk behavior&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Texas Department of State Health Services ==&lt;br /&gt;
&lt;br /&gt;
[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [1]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Philly Website ==&lt;br /&gt;
&lt;br /&gt;
[http://www.phillyhepatitis.org/support-care/ phillyhepatits.org] is an example of a resource for people seeking to identify if they have hepatitis, next steps they can take, and where they can find care or assistance.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== TLC Awareness Campaign ==&lt;br /&gt;
&lt;br /&gt;
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342624/ &amp;quot;Test, Listen, Cure&amp;quot; (TLC) Hepatitis C Community Awareness Campaign] provides information about how HCV infection is transmitted, risk factors for the disease, the importance of screening and treatment, and the availability of improved treatment for the disease.&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|TR - Improve Screening for Infectious Disease among Opioid Users]]&lt;br /&gt;
&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
#[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [2]] &lt;br /&gt;
#[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [3]] &lt;br /&gt;
#[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [4]] &lt;br /&gt;
##&lt;br /&gt;
##*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670662/ [5]]     &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_Screening_for_Infectious_Disease_among_Those_with_SUDs&amp;diff=19902</id>
		<title>Improve Screening for Infectious Disease among Those with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_Screening_for_Infectious_Disease_among_Those_with_SUDs&amp;diff=19902"/>
				<updated>2020-04-08T00:04:23Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19901 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;__NOTOC__Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]] &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;__TOC__ &lt;br /&gt;
= Current Status =&lt;br /&gt;
&lt;br /&gt;
*Hep C virus (HCV) infections tripled between 2010 and 2015 &lt;br /&gt;
*Substance abuse and infectious diseases shared common populations, risk factors, social determinants, and even contracting venues&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[1]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*There was little collaboration between programs that provided services to these populations&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[2]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*Methadone clinics would be optimal venues for service integration because these clinics serve a population that is 60% injection drug users; have medical staff performing brief health assessments for all new clients; and already have some infectious disease screenings in place, including routine tuberculosis testing and intermittent opt-in HIV testing&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[3]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*One study showed that 68% of opioid treatment programs nationwide had staff capacity for HCV testing, but only 33% actually offered on-site HCV testing&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[4]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #333333; font-family: roboto,'helvetica neue',helvetica,arial,sans-serif; font-size: 16px&amp;quot;&amp;gt;Awareness of HCV infection among this particular population may motivate them to reduce their consumption and hopefully high-risk behavior&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
= Barriers to Access =&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Texas Department of State Health Services ==&lt;br /&gt;
&lt;br /&gt;
[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [1]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Philly Website ==&lt;br /&gt;
&lt;br /&gt;
[http://www.phillyhepatitis.org/support-care/ phillyhepatits.org] is an example of a resource for people seeking to identify if they have hepatitis, next steps they can take, and where they can find care or assistance.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== TLC Awareness Campaign ==&lt;br /&gt;
&lt;br /&gt;
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342624/ &amp;quot;Test, Listen, Cure&amp;quot; (TLC) Hepatitis C Community Awareness Campaign] provides information about how HCV infection is transmitted, risk factors for the disease, the importance of screening and treatment, and the availability of improved treatment for the disease.&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|TR - Improve Screening for Infectious Disease among Opioid Users]]&lt;br /&gt;
&lt;br /&gt;
= Scorecard Building =&lt;br /&gt;
&lt;br /&gt;
[[PO_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Potential Objective Details]]&amp;lt;br/&amp;gt; [[PM_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Potential Measures and Data Sources]]&amp;lt;br/&amp;gt; [[PA_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Potential Actions and Partners]]&lt;br /&gt;
&lt;br /&gt;
= Resources to Investigate =&lt;br /&gt;
&lt;br /&gt;
[[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|More RTI ]][[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|on]][[RTI_-_Improve_Screening_for_Infectious_Disease_among_Opioid_Users|Improve Screening for Infectious Disease among Opioid Users]]&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
#[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [2]] &lt;br /&gt;
#[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [3]] &lt;br /&gt;
#[https://www.cdc.gov/nchhstp/programintegration/successstories-tx/inf-disease-screening.html [4]] &lt;br /&gt;
##&lt;br /&gt;
##*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670662/ [5]]     &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_Screening_for_Infectious_Disease_among_Those_with_SUDs&amp;diff=19901</id>
		<title>Improve Screening for Infectious Disease among Those with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_Screening_for_Infectious_Disease_among_Those_with_SUDs&amp;diff=19901"/>
				<updated>2020-04-08T00:04:07Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Number_of_Safe_Injection_Sites&amp;diff=19900</id>
		<title>Expand Number of Safe Injection Sites</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Number_of_Safe_Injection_Sites&amp;diff=19900"/>
				<updated>2020-04-08T00:01:29Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Number_of_Safe_Injection_Sites&amp;diff=19899</id>
		<title>Expand Number of Safe Injection Sites</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Number_of_Safe_Injection_Sites&amp;diff=19899"/>
				<updated>2020-04-07T23:59:29Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map&amp;amp;nbsp;or]] [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]]&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Background =&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot; style=&amp;quot;color: rgb(51, 51, 51); font-family: sans-serif,arial,verdana,&amp;amp;quot;trebuchet ms&amp;amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block;&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Safe injection sites are supervised sites designed to provide a hygienic and safe environment for illicit intravenous drug use and reduce nuisance from public drug use. Safe Injection sites are a cornerstone of harm reduction strategies towards drug problems. Typically injection sites provide sterile injection equipment, information about drugs and basic health care, treatment referrals, and access to medical staff to drug addicts. Currently there are no legal injection sites in the United States, however many other countries have employed them with levels of success.&amp;amp;nbsp;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Proposed Safe injection sites in the United States&amp;lt;/font&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Currently there are thirteen proposed injection sites in the United States. They are found in:&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Seattle &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Philadelphia&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Vermont&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Delaware&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;San Francisco&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;New York City&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Colorado&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Massachusetts&amp;lt;/font&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Positive Results from Safe Injection sites around the World&amp;lt;/font&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;SISs (Supervised Injection Sites) were efficacious in attracting the most marginalized PWID (People who inject Drugs), promoting safer injection conditions, enhancing access to primary health care, and reducing the overdose frequency. SISs were not found to increase drug injecting, drug trafficking or crime in the surrounding environments. SISs were found to be associated with reduced levels of public drug injections and dropped syringes.&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Best evidence from cohort and modeling studies suggests that SISs are associated with lower overdose mortality (88 fewer overdose deaths per 100 000 person-years [PYs]), 67% fewer ambulance calls for treating overdoses, and a decrease in HIV infections.&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;amp;nbsp; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255); color: rgb(34, 34, 34); font-family: arial,sans-serif; font-size: 12.8px;&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: rgb(77, 77, 77);&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255); color: rgb(255, 0, 0); font-family: arial,sans-serif; font-size: 12.8px;&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255); color: rgb(34, 34, 34); font-family: arial,sans-serif; font-size: 12.8px;&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: rgb(77, 77, 77);&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255); color: rgb(255, 0, 0); font-family: arial,sans-serif; font-size: 12.8px;&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot; style=&amp;quot;border-bottom-color: rgb(211, 211, 211); border-bottom-style: dotted; border-bottom-width: 1px; border-image-outset: 0; border-image-repeat: stretch; border-image-slice: 100%; border-image-source: none; border-image-width: 1; border-left-color: rgb(211, 211, 211); border-left-style: dotted; border-left-width: 1px; border-right-color: rgb(211, 211, 211); border-right-style: dotted; border-right-width: 1px; border-top-color: rgb(211, 211, 211); border-top-style: dotted; border-top-width: 1px;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;border-bottom-color: rgb(211, 211, 211); border-bottom-style: dotted; border-bottom-width: 1px; border-image-outset: 0; border-image-repeat: stretch; border-image-slice: 100%; border-image-source: none; border-image-width: 1; border-left-color: rgb(211, 211, 211); border-left-style: dotted; border-left-width: 1px; border-right-color: rgb(211, 211, 211); border-right-style: dotted; border-right-width: 1px; border-top-color: rgb(211, 211, 211); border-top-style: dotted; border-top-width: 1px;&amp;quot; | '''Reviewer'''&lt;br /&gt;
| style=&amp;quot;border-bottom-color: rgb(211, 211, 211); border-bottom-style: dotted; border-bottom-width: 1px; border-image-outset: 0; border-image-repeat: stretch; border-image-slice: 100%; border-image-source: none; border-image-width: 1; border-left-color: rgb(211, 211, 211); border-left-style: dotted; border-left-width: 1px; border-right-color: rgb(211, 211, 211); border-right-style: dotted; border-right-width: 1px; border-top-color: rgb(211, 211, 211); border-top-style: dotted; border-top-width: 1px;&amp;quot; | '''Date'''&lt;br /&gt;
| style=&amp;quot;border-bottom-color: rgb(211, 211, 211); border-bottom-style: dotted; border-bottom-width: 1px; border-image-outset: 0; border-image-repeat: stretch; border-image-slice: 100%; border-image-source: none; border-image-width: 1; border-left-color: rgb(211, 211, 211); border-left-style: dotted; border-left-width: 1px; border-right-color: rgb(211, 211, 211); border-right-style: dotted; border-right-width: 1px; border-top-color: rgb(211, 211, 211); border-top-style: dotted; border-top-width: 1px;&amp;quot; | '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;border-bottom-color: rgb(211, 211, 211); border-bottom-style: dotted; border-bottom-width: 1px; border-image-outset: 0; border-image-repeat: stretch; border-image-slice: 100%; border-image-source: none; border-image-width: 1; border-left-color: rgb(211, 211, 211); border-left-style: dotted; border-left-width: 1px; border-right-color: rgb(211, 211, 211); border-right-style: dotted; border-right-width: 1px; border-top-color: rgb(211, 211, 211); border-top-style: dotted; border-top-width: 1px;&amp;quot; | &amp;amp;nbsp;&lt;br /&gt;
| style=&amp;quot;border-bottom-color: rgb(211, 211, 211); border-bottom-style: dotted; border-bottom-width: 1px; border-image-outset: 0; border-image-repeat: stretch; border-image-slice: 100%; border-image-source: none; border-image-width: 1; border-left-color: rgb(211, 211, 211); border-left-style: dotted; border-left-width: 1px; border-right-color: rgb(211, 211, 211); border-right-style: dotted; border-right-width: 1px; border-top-color: rgb(211, 211, 211); border-top-style: dotted; border-top-width: 1px;&amp;quot; | &amp;amp;nbsp;&lt;br /&gt;
| style=&amp;quot;border-bottom-color: rgb(211, 211, 211); border-bottom-style: dotted; border-bottom-width: 1px; border-image-outset: 0; border-image-repeat: stretch; border-image-slice: 100%; border-image-source: none; border-image-width: 1; border-left-color: rgb(211, 211, 211); border-left-style: dotted; border-left-width: 1px; border-right-color: rgb(211, 211, 211); border-right-style: dotted; border-right-width: 1px; border-top-color: rgb(211, 211, 211); border-top-style: dotted; border-top-width: 1px;&amp;quot; | &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Access_to_Overdose_Reversal_Medications&amp;diff=19898</id>
		<title>Increase Access to Overdose Reversal Medications</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Access_to_Overdose_Reversal_Medications&amp;diff=19898"/>
				<updated>2020-04-07T23:45:59Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map&amp;amp;nbsp;or]] [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]]&amp;amp;nbsp;or [[ZOOM_Map-_Improve_Access_to_Treatments_that_Prevent_Overdose_Deaths|ZOOM MAP - Improve Access to Treatment that ]][[ZOOM_Map-_Improve_Access_to_Treatments_that_Prevent_Overdose_Deaths|Prevent]][[ZOOM_Map-_Improve_Access_to_Treatments_that_Prevent_Overdose_Deaths|&amp;amp;nbsp;Overdose Deaths]]&lt;br /&gt;
&lt;br /&gt;
= Naloxone (Narcan) =&lt;br /&gt;
&lt;br /&gt;
[[Additional_Info_on_Naloxone|Naloxone]] (Narcan) is a prescription medicine that can reverse an opioid overdose or prevent it long enough for the person to receive adequate medical care. It blocks the opioid receptors in the brain to prevent an opioid user’s breathing and heart rates from slowing to fatal levels. Beginning in 2016, thirty-five states have made Narcan available to the general public as an over-the-counter drug to use as a nasal spray. Many other states are now working to pass laws that give police, first responders, and concerned family members the ability to carry and administer Narcan when called to a possible overdose situation. It is either injected or administered in a nasal spray.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; While [[Additional_Info_on_Naloxone|Naloxone]] is not readily available by ordinary citizens, it can be easily administered with little or no formal training. State laws have made it difficult for citizens to obtain the life-saving medication, due to third-party prescription and prescription via standing order policies. The third party-prescription law prohibits the prescription of drugs to a third party other than whom the drugs will be given to, while the standing order law prohibits the prescription of drugs to a person not personally examined by the prescribing physician. Although, the drug could potentially save more lives if more widely distributed, there is fear of bystanders not summoning medical assistance due to possible prosecution against them.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; According to a report by CADCA, a small community in Connecticut has made training for first responders to an overdose mandatory. Officers found a man in an unconscious state and realized he was overdosing. With the administration of Narcan, the man was able to recover from the overdose and regain consciousness.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; Narcan has the potential to be very beneficial in communities with a high opioid problem. Making a community aware of it's existence, and it's power to reverse overdose is a benefit unlike any other. Narcan will allow victims of abuse to be more likely to survive an overdose when first responders are rightly prepared. This medicine is one of need if a community is struggling with an opioid problem.&amp;lt;br/&amp;gt; It has been effective in saving lives, giving people with addiction a chance to realize the depth of their problem and a chance to ask for help.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[1]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Evidence of Effectiveness ==&lt;br /&gt;
&lt;br /&gt;
There is some evidence that opioid overdose education and naloxone distribution programs increase knowledge of appropriate overdose response among participating opioid users and others likely to encounter an overdose situation. Naloxone distribution through such programs is associated with reduced overdose deaths and appears to increase participant's confidence in their ability to respond effectively to overdose situations. However, additional evidence is needed to confirm effects.&lt;br /&gt;
&lt;br /&gt;
Communities that implement programs to train potential bystanders to identify an opioid overdose and respond with naloxone appear to reduce opioid overdose death rates more than communities that do not implement such programs.&lt;br /&gt;
&lt;br /&gt;
Family and friends of opioid users have greater knowledge of opioid overdose and ability to respond appropriately after receiving training in naloxone administration than peers who learn about opioid overdose and naloxone via na information booklet. Current or former opioid users who have received training in overdose response appear to identify overdose and recognize conditions when naloxone is appropriate as accurately as medical experts. Some studies suggest that opioid users who have participated in only a brief 5-10 minute training or learned naloxone administration through social networks can respond appropriately to an overdose.&lt;br /&gt;
&lt;br /&gt;
Training first responders such as police, firefighters, and EMTs to administer naloxone may reduce time to overdose rescue, possibly decreasing overdose-related injury and death. Law enforcement officers who participate in naloxone administration adn overdose training report increases in knowledge and confidence in managing opioid overdose emergencies after program completion.&lt;br /&gt;
&lt;br /&gt;
A recent study in Massachusetts found that cities that have naloxone distribution programs have [http://www.bmj.com/content/346/bmj.f174 lower overdose death] rates than those that don’t. Similarly, the [http://www.nchrc.org/programs-and-services/ North Carolina Harm Reduction Coalition] has given out 52,000 naloxone kits since 2013 through their statewide grass roots network that includes syringe exchange and naloxone distribution, with more than 8,700 overdose reversals reported.&amp;lt;br/&amp;gt; [http://www.cadca.org/resources/coalition-action-meriden-healthy-youth-coalition-mhyc-provides-life-saving-overdose CADCA: Narcan Awareness]&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[2]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Educate about Dangers of Dual use =&lt;br /&gt;
&lt;br /&gt;
In 2013 there were 23,153 opioid overdose deaths -- 16,235 involving opioid painkillers, 8,260 involving heroin/opium, and at least 1,342 involving a combination of the two. However, opioid overdoses are seldom due to opioid use along; the majority are a result of mixing an opioid with some other drug. The best way to avoid opioid overdose is not taking opioids; the next best thing is to avoid drug mixing entirely. If you insist on mixing drugs in spite of the inherent dangers, then it is imperative to take extra safety precautions to not die when mixing drugs. These include:&lt;br /&gt;
&lt;br /&gt;
*Don't use alone &lt;br /&gt;
*Limit the amount of drugs you have available &lt;br /&gt;
*Stick to less lethal combinations of drugs &lt;br /&gt;
*Use smaller amounts of each drug &lt;br /&gt;
*Use the least impairing drug first &lt;br /&gt;
*Have Narcan on hand &lt;br /&gt;
*When injecting drugs of unknown strength and purity (street heroin), start with a small &amp;quot;tester&amp;quot; shot to gauge the strength of the drug before injecting a full dose &lt;br /&gt;
*When using a drug or drug combination for the first time, start with a small dose to gauge your innate tolerance &lt;br /&gt;
*Make sure your friends (or at least someone) knows what drug combinations you have taken &lt;br /&gt;
*Have a plan in place in case something goes wrong &lt;br /&gt;
&lt;br /&gt;
Narcan only works on opioids, but doesn't harm an individual in the case on non-opioid overdose. So if there's any question as to what a person took, use narcan; it can only help.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[6]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Waive Copays =&lt;br /&gt;
&lt;br /&gt;
Many people who are prescribed Narcan (nearly 35%) don’t pick it up—presumably because they can’t afford the co-pay.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[7]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp; Having insurers eliminate the co-pay is one strategy to help address that. [https://www.aetna.com/index.html?cid=ppc-700000001035216-National_Always%20On_Branded_Aetna_Exact-Aetna-aetna&amp;amp;s_dfa=1&amp;amp;gclid=Cj0KCQiA38jRBRCQARIsACEqIeuilyQ_mSIjuCUt394XAuPY7X7VLnJ16hmHFgFYPcLvvOwo4NUwmxkaAsEhEALw_wcB&amp;amp;gclsrc=aw.ds Aetna] is currently the first national payer to waive copays for Narcan for its fully-insured commercial members. This will &amp;quot;increase access and remove possible financial barriers to the lifesaving drug.&amp;quot;&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[8]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Legislation &amp;amp; Policy =&lt;br /&gt;
&lt;br /&gt;
== Good Samaritan Laws ==&lt;br /&gt;
&lt;br /&gt;
People often hesitate to seek treatment or call medical assistance in fear of incarceration or other form of punishment. In August of 2015, the White House announced a treatment-based initiative with $2.5 million going toward a pilot program that will engage law enforcement officers and public health professional to collect data on the movement of heroin along the East coast, and to train first responders on when it is adequate to administer Naloxone.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[9]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In 2006, New Mexico passed a [http://www.nytimes.com/2007/04/05/us/05drugs.html &amp;quot;Good Samaritan Law&amp;quot;] that &amp;quot;granted limited immunity from prosecution on simple possession chargers for people who dialed 911 to report a drug overdose&amp;quot;. By 2015, 28 states in addition to the District of Columbia had passed similar laws.&lt;br /&gt;
&lt;br /&gt;
In Minnesota, a &amp;quot;Good Samaritan&amp;quot; law was passed to assure that people who call the police or emergency responders to help with an overdose situation will not face legal consequences for their involvement, use of, or possession of legal or illegal opioids. This removes a potential barrier--fear of arrest--that sometimes leads to help not being called and lives being lost to overdose.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[10]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;[http://www.ncsl.org/research/civil-and-criminal-justice/drug-overdose-immunity-good-samaritan-laws.aspx Drug Overdose Immunity and Good Samaritan Laws] for minimizing the fears of calling for help in the case of an overdose.&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
== Increasing Awareness of Law ==&lt;br /&gt;
&lt;br /&gt;
*A University of Washington study evaluating the initial results of Washington state’s Good Samaritan policy found in a survey that drug users who were aware of the law were 88 percent more likely to call 911 in the event of an overdose than before.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[11]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; [http://adai.uw.edu/pubs/infobriefs/ADAI-IB-2011-05.pdf University of Washington study] &lt;br /&gt;
*After New York state passed its Good Samaritan law in 2011, for example, the Drug Policy Alliance printed 1 million cards and posters that explained the law and offered basic instructions on how to initially respond to an overdose, and worked with various agencies to help distribute these materials to vulnerable populations.&amp;lt;br/&amp;gt; [http://www.drugpolicy.org/sites/default/files/documents/DPA_911_GoodSam_Wallet_Card_v10_PRINTABLE.PDF Example Cards]&amp;lt;br/&amp;gt; [http://www.drugpolicy.org/sites/default/files/documents/DPA_911_Good_Samaritan_Flyer_EN_v3.pdf Example Posters] &lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
== Federal Changes to Address Problem ==&lt;br /&gt;
&lt;br /&gt;
Various federal organizations came together to encourage good faith prescription of naloxone to ordinary citizens and the second was to encourage bystanders to become &amp;quot;Good Samaritans&amp;quot; by summoning emergency responders without fear of negative legal consequences.&lt;br /&gt;
&lt;br /&gt;
== State Law Passage ==&lt;br /&gt;
&lt;br /&gt;
By the end of 2016, all but 3 states, Kansas, Montana, and Wyoming, have passed laws to improve ordinary person naloxone access.&lt;br /&gt;
&lt;br /&gt;
== Pharmacists ==&lt;br /&gt;
&lt;br /&gt;
In California, The California State Board of Pharmacy passed a policy that allows pharmacists to give out Naloxone (Narcan) without a prescription in case of emergencies.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[12]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= New in 2016: Improved Access to Nasal Narcan =&lt;br /&gt;
New Public Interest Pricing $37.50 per dose &amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;[[Media:Press_Release_for_Adapt_Pharma_and_Public_Interest_Pricing.pdf|Press Release for Adapt Pharma and Public Interest Pricing.pdf]]&amp;amp;nbsp; (230 KB)&amp;lt;/div&amp;gt; &amp;lt;br/&amp;gt; Free case of Narcan Nasal for any school. (Only 9 states allow as of Jan 2016). &amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;&amp;lt;div&amp;gt;[[Media:Free_Narcan_Nasal_Spray_and_Education_for_High_Schools.pdf|Free Narcan Nasal Spray and Education for High Schools.pdf]]&amp;amp;nbsp; (164 KB)&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
= Law Enforcement Use of Naloxone =&lt;br /&gt;
&lt;br /&gt;
*A 2016 report by the Police Executive Research Forum provides case examples of law enforcement naloxone programs instituted in Fayetteville (NC), Lummi Nation (WA), Virginia Beach (VA), Staten Island (NY), Camden County (CJ), Mongomery County (MD), and Hagerstown (MD) including descriptions of training, funding, administration and support.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[13]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*[[EI_-_Librarians_&amp;amp;_Access_to_Overdose_Treatment|EI - Librarians &amp;amp; Access to Overdose Treatment]]&amp;amp;nbsp;The Bureau of Justice Assistance (BJA) maintains an online toolkit featuring resources and information on naloxone, including a section on liability and risk for law enforcement officers and their employers associated with naloxone administration.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[14]&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Database of State Legislative Efforts =&lt;br /&gt;
&lt;br /&gt;
This [http://www.ncsl.org/research/health/prevention-of-prescription-drug-overdose-and-abuse.aspx site] has many examples of policy efforts that have been attempted or passed.&lt;br /&gt;
&lt;br /&gt;
=== Prevent Overdose strategies ===&lt;br /&gt;
&lt;br /&gt;
This [https://www.overdosepreventionstrategies.org/ link] is a resource that has put every state's strategy into an online resource hub. This gives users a free resource to see what is being enacted in other states and lets people compare and contrast. This will allow for communities to enter and see what works and what does not.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;[https://www.overdosepreventionstrategies.org/ Overdose Prevention Strategies]&lt;br /&gt;
&lt;br /&gt;
= Engaging Diverse Community Partners =&lt;br /&gt;
&lt;br /&gt;
[[CP_-_Improve_Access_to_Treatments_that_Prevent_Overdose_Deaths|CP - Improve Access to Treatments that Prevent Overdose Deaths]]&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Improve_Access_to_Treatment_that_Prevent_Overdose_Deaths|TR - Improve Access to Treatment that Prevent Overdose Deaths]]&amp;lt;br/&amp;gt; [http:///file/view/SAMHSA_Opioid_Overdose_Prevention_TOOLKIT.pdf/613626145/SAMHSA_Opioid_Overdose_Prevention_TOOLKIT.pdf SAMHSA- Opioid Overdose Prevention Toolkit] - In particular, sections Facts for Community Members and Information for Prescribers may be of special interest.&lt;br /&gt;
&lt;br /&gt;
= Actions to Take =&lt;br /&gt;
&lt;br /&gt;
[[PA_-_Improve_Access_to_Treatment_that_Prevent_Overdose_Deaths|Actions for Coalitions]]&lt;br /&gt;
&lt;br /&gt;
[[PAI_-_Improve_Access_to_Treatment_that_Prevent_Overdose_Deaths|Actions for Individuals]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; '''PAGE MANAGER''': [insert name here]&amp;lt;br/&amp;gt; '''SUBJECT MATTER EXPERT''': [fill out table below]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| Reviewer&lt;br /&gt;
| Date&lt;br /&gt;
| Comments&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
#Hazelden Betty Ford Foundation. Heroin and Prescription Painkillers: A Toolkit for Community Action. 2016. &lt;br /&gt;
#CACDA Administration of Narcan. 2017&amp;amp;nbsp;&amp;amp;nbsp;[http://www.cadca.org/resources/coalition-action-meriden-healthy-youth-coalition-mhyc-provides-life-saving-overdose [1]] &lt;br /&gt;
#100 Million Healthier Lives City, Town-Wide, and Regional Efforts.[https://www.baltimorecountymd.gov/news/baltimorecountynow/Kamenetz_Announces_Significant_County_Substance_Abuse_Initiatives_ https://www.baltimorecountymd.gov/news/baltimorecountynow/Kamenetz_Announces_Significant_County_Substance_Abuse_Initiatives_] &lt;br /&gt;
#100 Million Healthier Lives City, Town-Wide, and Regional Efforts [https://www.baltimorecountymd.gov/news/baltimorecountynow/Kamenetz_Announces_Significant_County_Substance_Abuse_Initiatives_ https://www.baltimorecountymd.gov/news/baltimorecountynow/Kamenetz_Announces_Significant_County_Substance_Abuse_Initiatives_] &lt;br /&gt;
#100 Million Healthier Lives City, Town-Wide, and Regional Efforts.[https://www.baltimorecountymd.gov/news/baltimorecountynow/Kamenetz_Announces_Significant_County_Substance_Abuse_Initiatives_ [2]] &lt;br /&gt;
#[http://www.rehabs.com/pro-talk-articles/the-ultimate-harm-reduction-guide-to-drug-mixing/ http://www.rehabs.com/pro-talk-articles/the-ultimate-harm-reduction-guide-to-drug-mixing/] &lt;br /&gt;
#[https://news.aetna.com/2017/12/aetna-announces-new-policies-improve-access-narcan-combat-overprescribing/ https://news.aetna.com/2017/12/aetna-announces-new-policies-improve-access-narcan-combat-overprescribing/] &lt;br /&gt;
#[https://news.aetna.com/2017/12/aetna-announces-new-policies-improve-access-narcan-combat-overprescribing/ https://news.aetna.com/2017/12/aetna-announces-new-policies-improve-access-narcan-combat-overprescribing/] &lt;br /&gt;
#[http://www.slate.com/articles/news_and_politics/crime/2015/08/good_samaritan_drug_laws_they_save_lives_and_more_states_should_pass_them.html http://www.slate.com/articles/news_and_politics/crime/2015/08/good_samaritan_drug_laws_they_save_lives_and_more_states_should_pass_them.html] &lt;br /&gt;
#[http://www.minnesotarecovery.org/files/FINAL_Good_Samaritan_Postcard.pdf http://www.minnesotarecovery.org/files/FINAL_Good_Samaritan_Postcard.pdf] &lt;br /&gt;
#[http://www.slate.com/articles/news_and_politics/crime/2015/08/good_samaritan_drug_laws_they_save_lives_and_more_states_should_pass_them.html http://www.slate.com/articles/news_and_politics/crime/2015/08/good_samaritan_drug_laws_they_save_lives_and_more_states_should_pass_them.html] &lt;br /&gt;
#[http://www.pharmacy.ca.gov/publications/naloxone_media_release.pdf http://www.pharmacy.ca.gov/publications/naloxone_media_release.pdf] &lt;br /&gt;
#Police Executive Research Forum. 2016. Building Successful Partnerships between Law Enforcement and Public Health Agencies to Address Opioid Use. COPS Office Emerging Issues Forums. Washington, DC: Office of Community Oriented Policing Services.&amp;lt;br/&amp;gt; [https://ric-zai-inc.com/Publications/cops-p356-pub.pdf https://ric-zai-inc.com/Publications/cops-p356-pub.pdf] &lt;br /&gt;
#[https://www.bjatraining.org/tools/naloxone/Liability-and-Risk https://www.bjatraining.org/tools/naloxone/Liability-and-Risk] &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Full Spectrum Prevention]] [[Category:SAFE-Treatment and Recovery]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Adopt_Harm_Reduction_Practices_in_Jails_and_Prisons&amp;diff=19897</id>
		<title>Adopt Harm Reduction Practices in Jails and Prisons</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Adopt_Harm_Reduction_Practices_in_Jails_and_Prisons&amp;diff=19897"/>
				<updated>2020-04-07T23:43:52Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Mapor]] [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]]&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
== Hepatitis C ==&lt;br /&gt;
&lt;br /&gt;
Hepatitis C is more than three times more prevalent among people who inject drugs than HIV. In most countries, more than half the people who inject drugs live with Hepatitis C. The level of Hepatitis C infection amongst US prisoners is substantially higher than the general population: between 12 and 35 percent of prison inmates are infected with hepatitis C, compared to between 1 and 2 percent of the general population.&amp;lt;sup&amp;gt;[1]&amp;lt;/sup&amp;gt; Global HIV prevalence is up to 50 times higher among the prison population than in the general public, while one in four detainees worldwide is living with Hepatitis C.&amp;quot;&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[2]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Preventing the Spread of Hepatitis C by Treating Infected Prisoners ==&lt;br /&gt;
&lt;br /&gt;
WHO, the United Nations Office on Drugs and Crime and UNAIDS recommended in 2007 that &amp;quot;prison authorities in countries experiencing or threatened by an epidemic of HIV infections among people who inject drugs should introduce and scale up Needle and Syringe Programs (NSPs) urgently.&amp;quot;&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[3]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
An analysis of studies of European Prison NSPs &amp;quot;Ten Year of Experience with Needle and Syringe Exchange Programs in European Prisons&amp;quot; concluded that prison NSPs are not only feasible but effective, especially when embedded within a comprehensive prison-based harm reduction and health-promotion strategy.&amp;quot;&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[4]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
There is increasing evidence that experience of imprisonment is a strong predictor of HIV and Hep C transmission for the individual prisoners. Nor is this an issue confined to prison. A majority of prisoners serve short-term sentences, during which they are unable to access long term drug treatment, and return to the wider community having been at significantly higher risk of Blood Borne Virus transmission and subsequently more likely to pass on Blood Borne Viruses. For this reason prisons have been called HIV and Hep C incubators.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[5]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Syringe Economy ==&lt;br /&gt;
&lt;br /&gt;
Syringes in prisons without Needle Syringe programs are sold on illicit markets and very expensive, given high demand and scarcity. In prisons where NSPs operate however, there has not been any illicit market reported where needles and syringes are accessible.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[6]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Prison Needle Syringe Program Studies =&lt;br /&gt;
&lt;br /&gt;
These findings come from a Harm Reduction International study on HIV, Hep C, TB and Harm Reduction in Prisons&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[7]&amp;lt;/sup&amp;gt; . This 2016 study found that:&lt;br /&gt;
&lt;br /&gt;
*Prison NSPs are feasible and affordable across a wide range of prison settings &lt;br /&gt;
*Prison NSP are effective in decreasing syringe sharing among people who inject drugs in prison, thereby decreasing the risk of blood borne virus transmission between prisoners and from prisoners to prison staff &lt;br /&gt;
*Prison NSP are not associated with increased attacks on prison staff or other prisoners &lt;br /&gt;
*Prison NSP do not lead to increased initiation of drug consumption or injection &lt;br /&gt;
*Prison NSP contribute to workplace safety &lt;br /&gt;
*Prison NSP can reduce the incidence of acscesses &lt;br /&gt;
*Prison NSP facilitate referral to available drug-dependence treatment programs &lt;br /&gt;
*Prison NSP can be delivered successfully via a range of methods in response to staff and inmate needs &lt;br /&gt;
*Prison NSP are effective in a wide range of prison systems &lt;br /&gt;
*Prison NSP can successfully coexist with other drug prevention and drug dependence treatment programs &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; Important factors in the success of prison NSPs include:&lt;br /&gt;
&lt;br /&gt;
*Easy and confidential access to the service &lt;br /&gt;
*Providing the right type of syringes &lt;br /&gt;
*Building trust with the prisoners accessing the program &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; Germany, Switzerland, and Spain had 19 programs in total by 2000. Evaluations of these pilot programs have shown that the aims of the programs have been achieved. These include:&lt;br /&gt;
&lt;br /&gt;
*Reduction in syringe sharing &lt;br /&gt;
*Subsequent reduction in Blood borne Virus rates &lt;br /&gt;
*No increase in drug use &lt;br /&gt;
*No syringes used as weapons &lt;br /&gt;
&lt;br /&gt;
= Models of Prison NSPs =&lt;br /&gt;
&lt;br /&gt;
There are four main models of prison needle exchange programs&lt;br /&gt;
&lt;br /&gt;
#'''Hand-to-hand distribution by prison health staff, social workers, physicians, or nurses'''. This method is used in several Spanish and Swiss prisons. The used syringes are either exchanged at the cell door or in the medical unit. &lt;br /&gt;
#'''Hand-to-hand distribution by trained peers''' (i.e., prisoners) to ensure confidential contact with prisoners who use drugs as well as access at almost all times. This system is mostly used in Moldovan prisons. &lt;br /&gt;
#'''Hand-to-hand distribution by external personnel or NGOs''' who also provide other harm reduction services. &lt;br /&gt;
#'''Automated dispensing machines''' e.g., Germany and Hindelbank women's prison, Switzerland (one-for-one exchange, starting with a dummy syringe as the first device). &lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Adopt_Harm_Reduction_Practices_in_Prisons|TR - Adopt Harm Reduction Practices in Prisons]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
#[https://www.globalcommissionondrugs.org/hepatitis/gcdp_hepatitis_english.pdf [1]] &lt;br /&gt;
#[https://www.hri.global/files/2016/02/10/HRI_PrisonProjectReport_FINAL.pdf [2]] &lt;br /&gt;
#[http://www.aivl.org.au/wp-content/uploads/NSP-in-Prisons-An-International-Review.pdf [3]] &lt;br /&gt;
#[http://www.aivl.org.au/wp-content/uploads/NSP-in-Prisons-An-International-Review.pdf [4]] &lt;br /&gt;
#[https://www.hri.global/files/2016/02/10/HRI_PrisonProjectReport_FINAL.pdf [5]] &lt;br /&gt;
#[https://www.hri.global/files/2016/02/10/HRI_PrisonProjectReport_FINAL.pdf [6]] &lt;br /&gt;
#[https://www.hri.global/files/2016/02/10/HRI_PrisonProjectReport_FINAL.pdf [7]] &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Access_to_Needle_Exchanges&amp;diff=19896</id>
		<title>Increase Access to Needle Exchanges</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Access_to_Needle_Exchanges&amp;diff=19896"/>
				<updated>2020-04-07T23:39:02Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;__NOTOC__ &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map or]] [[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|Zoom Map (Expand Harm Reduction Practices Associated with Opioid Misuse)]] &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&amp;amp;nbsp; __toc__ &lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
Needle exchange programs (NEPs) are programs which distribute sanitized needles in exchange for contaminated or used needles. NEPs reduce the spread of blood borne diseases like HIV and Hepatitis C.&lt;br /&gt;
&lt;br /&gt;
Many Organizations have endorsed needle exchange including NIH (National Institute of Health), CDC (Center for Disease Control), the American Bar Association, the American Medical Association, the American Psychological Association, the World Health Organization and others.&amp;lt;ref&amp;gt;https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.1840360703 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The NIH estimates that in the United States, between fifteen and twenty percent of injection drug users have HIV and at least seventy percent have hepatitis C.&amp;lt;ref&amp;gt;https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.1840360703 &amp;lt;/ref&amp;gt; &amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;As such sharing needles has become the most common mode of HIV transmission among injection drug users (IDUs). In addition, used syringes and needles are a potential biohazard within which users primarily reside, and beyond it as well.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;Harm reduction services such as the provision of sterile needles and syringes can effectively prevent hepatitis C and HIV transmission among people who inject drugs, provided they are accessible and delivered at the required scale.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;Needle exchanges have been estimated to be a cost effective prevention practice. An analysis of the cost-effectiveness of a New York City needle syringe exchange estimated that the program would result in a baseline one year savings to the government of $1,300 to $3,000 per client. Another analysis by the CDC approximated that increasing access to clean syringes through an additional annual U.S. investment of $10 million would lead to:&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;194 HIV infections averted in one year&amp;amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;ref&amp;gt;https://www.cdc.gov/policy/hst/hi5/cleansyringes/index.html&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;And A lifetime treatment cost savings of $75.8 million which would be a return on investment of $7.58 for every $1 spent&amp;amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;ref&amp;gt;https://www.cdc.gov/policy/hst/hi5/cleansyringes/index.html&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Do Needle Exchanges Increase Drug Injection Rates? =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-family:&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;A review of needle exchange done by the office of the Surgeon General and the assistant secretary for health found that needle exchange did not cause an increase in drug injection, but rather typically led to a decrease in injection rates when these programs were used.&amp;lt;ref&amp;gt;http://www.csdp.org/research/surgeongennex.pdf&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Another study sought to answer the question &amp;quot;is the number of needles distributed from needle exchange programs proportionate to the number of needles returned to needle exchange programs?&amp;quot; It was found that in the United States the return rate was on average over 90% (~315,000 needles distributed and ~283,000 needles returned).&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
This finding has been further substantiated by another review which found that supplying IDUs (Injecting Drug Users) with clean or sanitized needles does not lead to more &amp;quot;dirty&amp;quot; needles in a community.&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Different Models for Syringe Exchanges =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-family:&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;There are currently several different models for syringe exchanges that have different advantages and limitations. The models include:&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-family:&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;'''Primary and Secondary Needle and Syringe Programs''':&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;They are fixed sites that are typically located in areas with high levels of injecting drug use.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;They can be located in many different areas such as community centers, pharmacies, or specialized voluntary counselling and testing centers.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;Those who attend will be able to receive clean paraphernalia and safely dispose of used paraphernalia.&amp;amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;font-size:11.0pt&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:107%&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-family:&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;ref&amp;gt;https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
'''Mobile or On-Call Service''':&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;Mobile programs operate from a van or bus with clean needles that are distributed.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**Larger mobile programs typically provide testing and other healthcare services and operate along regular reoutes at fixed times, often at night at times when increased use occurs. &lt;br /&gt;
**Mobile services can also be smaller and choose to target specific populations.   &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list 1.0in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;Typically, mobile programs are more accessible to injection drug users and face less opposition from a community.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;amp;nbsp;&amp;lt;span style=&amp;quot;font-size:11.0pt&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:107%&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-family:&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;ref&amp;gt;https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#000000&amp;quot; face=&amp;quot;calibri, sans-serif&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-size: 14.6667px;&amp;quot;&amp;gt;'''Dispensing Machine Distribution''':&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;A newer strategy, countries in Europe as well as Australia have begun to use syringe vending machines in addition to other forms of NSPs.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;Syringe vending machines work through the use of non-currency tokens, that are distributed by outreach workers for injection drug users to use in return for harm reduction packs. An example of what is included in Australia’s machines are needles and syringes as well as alcohol swabs, cotton wool, sterile water and spoons. Others sometimes contain educational materials.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;Typically, these machines act in conjunction with fixed sites that are meant to provide needles and syringes 24 hours a day, 7 days a week.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;A clinical trial has found that this strategy can be highly effective for reaching populations who are most marginalized or otherwise hard to reach.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;font-size:11.0pt&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:107%&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-family:&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;ref&amp;gt;https://www.avert.org/professionals/hiv-programming/prevention/needle-syringe-programmes&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#000000&amp;quot;&amp;gt;&amp;lt;font face=&amp;quot;calibri, sans-serif&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-size:14.6667px&amp;quot;&amp;gt;'''Peer Service Distribution Networks'''&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;span style=&amp;quot;font-size:11.0pt&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:107%&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;font-family:&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;:&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;Peer-based strategy, is a&amp;amp;nbsp;process where clients of needle exchanges provide service to their peers, distributing of needles, syringes, and associated injection equipment.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;These clients are trained to assist peers access exchangers, distribute information about safer drug use and safer sex, and facilitate referrals to other health services.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;This model, in addition to disseminating safer practices and helping make needle exchange programs reach a larger population, may have a psychological impact and help make interventions more effective.&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241304/&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;'''Prison-Based Facilities''':&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;Still a newly developing practice, only used in 3 of 24 UN countries that have needle exchange programs for the public.&amp;lt;ref&amp;gt;http://blogs.biomedcentral.com/on-health/wp-content/uploads/sites/8/2016/10/Prison-based-needle-and-syringe-programmes-PNSP-final.pdf&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;tab-stops:list .5in&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;vertical-align:baseline&amp;quot;&amp;gt;High need because prison populations have higher cases of Hepatitis C and HIV than the average population.&amp;amp;nbsp;&amp;lt;ref&amp;gt;http://blogs.biomedcentral.com/on-health/wp-content/uploads/sites/8/2016/10/Prison-based-needle-and-syringe-programmes-PNSP-final.pdf&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Importance for Harm Reduction Practice and Education =&lt;br /&gt;
&lt;br /&gt;
Needle exchange programs help educate and inform injection drug users regarding injection practices, safety steps, non-sharing behavior, and other risk reduction methods. “The need for and value of targeted education and behavior modification efforts directed at injection drug users at risk of HIV transmission have been clearly demonstrated in programs that do not include needle exchange (Wiebel et al., 1993).”&amp;lt;font color=&amp;quot;#000000&amp;quot;&amp;gt;&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/books/NBK232350/&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Success Stories =&lt;br /&gt;
&lt;br /&gt;
'''Scott County, Indianna'''&lt;br /&gt;
&lt;br /&gt;
Before Scott County set up its syringe exchange (plus more) program in 2015, the rural county in Indiana was seeing 10-20 new HIV cases every week. Almost immediately after, the number of new cases was slowed to 1-2 a month&lt;br /&gt;
&lt;br /&gt;
Miami, Florida&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;“In three years of operation, Miami's pilot program has pulled more than a quarter million used needles out of circulation, according to reports the program filed with the Florida Department of Health.” By handing out Narcan as well at the needle exchange, it has helped prevent more than a thousand overdoses. The program also offers clients testing for HIV and hepatitis C and connects people to medical care and rehabilitation services.&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.npr.org/sections/health-shots/2019/06/27/725462715/key-florida-republicans-now-say-yes-to-clean-needles-for-drug-users&amp;lt;/ref&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;span style=&amp;quot;line-height:normal&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:black&amp;quot;&amp;gt;Philidelphia, Pennsylvania&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
A case study found that Prevention Point, a needle exchange located in Philadelphia helped prevent 10,000 People From Contracting HIV Over 10 Years. The researchers from George Washington University estimate that the total lifetime taxpayer savings from this needle exchange averting 10,000 cases of HIV saved them $1.8 billion.&amp;amp;nbsp;&amp;lt;ref&amp;gt;https://www.phillymag.com/news/2019/10/31/prevention-point-syringe-exchange-study/&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Access_to_Needle_Exchanges|TR - Increase Access to Needle Exchanges]] &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
Sources&lt;br /&gt;
&lt;br /&gt;
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [4]] &lt;br /&gt;
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [5]] &lt;br /&gt;
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [6]] &lt;br /&gt;
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [7]] &lt;br /&gt;
#[http://www.alaskapublic.org/2017/06/28/wave-of-addiction-costs-is-hitting-alaskas-healthcare-system/ [8]] &lt;br /&gt;
#[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/ [9]] &lt;br /&gt;
#[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC419716/ [10]] &lt;br /&gt;
#[http://sideeffectspublicmedia.org/post/indiana-law-makes-harm-reduction-opioid-addiction-yearly-battle [11]] &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Full Spectrum Prevention]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_SBIRT_in_Maternity_Care_Clinics&amp;diff=19895</id>
		<title>Expand SBIRT in Maternity Care Clinics</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_SBIRT_in_Maternity_Care_Clinics&amp;diff=19895"/>
				<updated>2020-04-07T23:30:38Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;__NOTOC__ &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to&amp;amp;nbsp; [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]]&amp;amp;nbsp;or&amp;amp;nbsp;[[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]&lt;br /&gt;
&amp;lt;div id=&amp;quot;toc&amp;quot;&amp;gt;&lt;br /&gt;
= Table of Contents =&lt;br /&gt;
&amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Background|Background]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Best_Practices|Best Practices]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Increase_Uptake_of_SBIRT|Increase Uptake of SBIRT]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Promising_Programs|Promising Programs]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 2em&amp;quot;&amp;gt;[[#Promising_Programs-Ultrasound_Feedback|Ultrasound Feedback]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 2em&amp;quot;&amp;gt;[[#Promising_Programs-Educating_Medical_Students|Educating Medical Students]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Tools_.26_Resources|Tools &amp;amp; Resources]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Sources|Sources]]&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
SBIRT (Screening, Brief Intervention, Referral to Treatment) is &amp;quot;a comprehensive, integrated, public health approach to the delivery of early intervention and treatment services for persons with substance use disorders, as well as those who are at risk of developing these disorders&amp;quot; and has been widely acknowledged as an evidenced-based practice.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[1]&amp;lt;/sup&amp;gt; It helps identify the level of risk associated with alcohol or substance use.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; Early identification of substance use allows for early intervention and treatment which minimizes potential harms to the mother and her pregnancy.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[2]&amp;lt;/sup&amp;gt; Selective screening based on “risk factors” perpetuates stigma and misses most women with problematic use. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[3]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; The goals of SBIRT include:&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[4]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Educate people about the risks of alcohol and other drugs &lt;br /&gt;
*Make people aware of their use and whether it may be creating health risks for them &lt;br /&gt;
*Decrease general use so as to reduce the societal risk and burden of the effects of overuse &lt;br /&gt;
*Identify individuals who have dependence and provide rapid access to care &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Best Practices =&lt;br /&gt;
&lt;br /&gt;
#Use non-judgmental and caring tone - Patients are usually not offended by questions about substance use if asked in caring and nonjudgmental manner. &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; 2. Normalize questions:&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – Embed them in other health behavior questions&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – Preface questions by stating that all patients are asked about substance use&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp; 3. Ask permission&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – “Is it OK if I ask you some questions about smoking, alcohol and other drugs?&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp; 4. Avoid closed-ended questions&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – “You don’t smoke or use drugs, do you?”&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Increase Uptake of SBIRT =&lt;br /&gt;
&lt;br /&gt;
*Embed it in standard of care &lt;br /&gt;
**Staff-wide trainings &lt;br /&gt;
**EMR &lt;br /&gt;
**Routine part of QA Evaluation   &lt;br /&gt;
*Don't rely exclusively on physicians &lt;br /&gt;
**Physicians (especially primary care physicians) are overburdened by time and an increasing load of screenings &lt;br /&gt;
**Think creatively about staff, screening and brief interventions   &lt;br /&gt;
*Expand types of screening &lt;br /&gt;
**Patient completed &lt;br /&gt;
**Nurse/staff administered &lt;br /&gt;
**Computer-assisted   &lt;br /&gt;
*Expand types of intervention &lt;br /&gt;
**Computer-based &lt;br /&gt;
**Peer-based &lt;br /&gt;
**Other staff   &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Ultrasound Feedback ==&lt;br /&gt;
&lt;br /&gt;
One study showed that real-time ultrasound feedback focused on the potential effects of smoking on the fetus may be an effective treatment adjunct to improve smoking outcomes.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[5]&amp;lt;/sup&amp;gt; This could be adapted and used to treat women with other types of SUDs as well.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Educating Medical Students ==&lt;br /&gt;
&lt;br /&gt;
A 2012 study of medical students in an obstetrics and gynecology rotation found that when students are placed in a residential treatment center for pregnant women (i.e. specialized training) they showed greater comfort in assessing and educating patients about substance abuse during pregnancy compared to those in a regular rotation.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[6]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Expand_SBIRT_in_Maternity_Care_Clinics|TR - Expand SBIRT in Maternity Care Clinics]]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
#[https://www.samhsa.gov/sbirt/about [1]] &lt;br /&gt;
#[http://www.cffutures.org/files/webinar-handouts/Substance%20Use%20in%20Pregnancy_Final.pdf [2]] &lt;br /&gt;
#[http://www.cffutures.org/files/webinar-handouts/Substance%20Use%20in%20Pregnancy_Final.pdf [3]] &lt;br /&gt;
#[https://www.samhsa.gov/sites/default/files/programs_campaigns/women_children_families/womens-health.pdf [4]] &lt;br /&gt;
#[https://www.researchgate.net/publication/26317678_Ultrasound_feedback_and_motivational_interviewing_targeting_smoking_cessation_in_the_second_and_third_trimesters_of_pregnancy [5]] &lt;br /&gt;
#[https://www.ncbi.nlm.nih.gov/pubmed/23154692 [6]] &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Full Spectrum Prevention]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_SBIRT_in_Maternity_Care_Clinics&amp;diff=19894</id>
		<title>Expand SBIRT in Maternity Care Clinics</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_SBIRT_in_Maternity_Care_Clinics&amp;diff=19894"/>
				<updated>2020-04-07T23:30:07Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;__NOTOC__ &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to&amp;amp;nbsp; [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]]&amp;amp;nbsp;or&amp;amp;nbsp;[[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]&lt;br /&gt;
&amp;lt;div id=&amp;quot;toc&amp;quot;&amp;gt;&lt;br /&gt;
= Table of Contents =&lt;br /&gt;
&amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Background|Background]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Best_Practices|Best Practices]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Increase_Uptake_of_SBIRT|Increase Uptake of SBIRT]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Promising_Programs|Promising Programs]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 2em&amp;quot;&amp;gt;[[#Promising_Programs-Ultrasound_Feedback|Ultrasound Feedback]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 2em&amp;quot;&amp;gt;[[#Promising_Programs-Educating_Medical_Students|Educating Medical Students]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Tools_.26_Resources|Tools &amp;amp; Resources]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Scorecard_Building|Scorecard Building]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Resources_to_Investigate|Resources to Investigate]]&amp;lt;/div&amp;gt; &amp;lt;div style=&amp;quot;margin-left: 1em&amp;quot;&amp;gt;[[#Sources|Sources]]&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
SBIRT (Screening, Brief Intervention, Referral to Treatment) is &amp;quot;a comprehensive, integrated, public health approach to the delivery of early intervention and treatment services for persons with substance use disorders, as well as those who are at risk of developing these disorders&amp;quot; and has been widely acknowledged as an evidenced-based practice.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[1]&amp;lt;/sup&amp;gt; It helps identify the level of risk associated with alcohol or substance use.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; Early identification of substance use allows for early intervention and treatment which minimizes potential harms to the mother and her pregnancy.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[2]&amp;lt;/sup&amp;gt; Selective screening based on “risk factors” perpetuates stigma and misses most women with problematic use. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[3]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; The goals of SBIRT include:&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[4]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Educate people about the risks of alcohol and other drugs &lt;br /&gt;
*Make people aware of their use and whether it may be creating health risks for them &lt;br /&gt;
*Decrease general use so as to reduce the societal risk and burden of the effects of overuse &lt;br /&gt;
*Identify individuals who have dependence and provide rapid access to care &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Best Practices =&lt;br /&gt;
&lt;br /&gt;
#Use non-judgmental and caring tone - Patients are usually not offended by questions about substance use if asked in caring and nonjudgmental manner. &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; 2. Normalize questions:&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – Embed them in other health behavior questions&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – Preface questions by stating that all patients are asked about substance use&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp; 3. Ask permission&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – “Is it OK if I ask you some questions about smoking, alcohol and other drugs?&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp; 4. Avoid closed-ended questions&amp;lt;br/&amp;gt; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp; – “You don’t smoke or use drugs, do you?”&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Increase Uptake of SBIRT =&lt;br /&gt;
&lt;br /&gt;
*Embed it in standard of care &lt;br /&gt;
**Staff-wide trainings &lt;br /&gt;
**EMR &lt;br /&gt;
**Routine part of QA Evaluation   &lt;br /&gt;
*Don't rely exclusively on physicians &lt;br /&gt;
**Physicians (especially primary care physicians) are overburdened by time and an increasing load of screenings &lt;br /&gt;
**Think creatively about staff, screening and brief interventions   &lt;br /&gt;
*Expand types of screening &lt;br /&gt;
**Patient completed &lt;br /&gt;
**Nurse/staff administered &lt;br /&gt;
**Computer-assisted   &lt;br /&gt;
*Expand types of intervention &lt;br /&gt;
**Computer-based &lt;br /&gt;
**Peer-based &lt;br /&gt;
**Other staff   &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Ultrasound Feedback ==&lt;br /&gt;
&lt;br /&gt;
One study showed that real-time ultrasound feedback focused on the potential effects of smoking on the fetus may be an effective treatment adjunct to improve smoking outcomes.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[5]&amp;lt;/sup&amp;gt; This could be adapted and used to treat women with other types of SUDs as well.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Educating Medical Students ==&lt;br /&gt;
&lt;br /&gt;
A 2012 study of medical students in an obstetrics and gynecology rotation found that when students are placed in a residential treatment center for pregnant women (i.e. specialized training) they showed greater comfort in assessing and educating patients about substance abuse during pregnancy compared to those in a regular rotation.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[6]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Expand_SBIRT_in_Maternity_Care_Clinics|TR - Expand SBIRT in Maternity Care Clinics]]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
#[https://www.samhsa.gov/sbirt/about [1]] &lt;br /&gt;
#[http://www.cffutures.org/files/webinar-handouts/Substance%20Use%20in%20Pregnancy_Final.pdf [2]] &lt;br /&gt;
#[http://www.cffutures.org/files/webinar-handouts/Substance%20Use%20in%20Pregnancy_Final.pdf [3]] &lt;br /&gt;
#[https://www.samhsa.gov/sites/default/files/programs_campaigns/women_children_families/womens-health.pdf [4]] &lt;br /&gt;
#[https://www.researchgate.net/publication/26317678_Ultrasound_feedback_and_motivational_interviewing_targeting_smoking_cessation_in_the_second_and_third_trimesters_of_pregnancy [5]] &lt;br /&gt;
#[https://www.ncbi.nlm.nih.gov/pubmed/23154692 [6]] &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Full Spectrum Prevention]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19893</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19893"/>
				<updated>2020-04-07T23:25:15Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19892 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
[https://www.cdc.gov/pregnancy/opioids/basics.html https://www.cdc.gov/pregnancy/opioids/basics.html]&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19892</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19892"/>
				<updated>2020-04-07T23:23:56Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19891</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19891"/>
				<updated>2020-04-07T23:21:47Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19890 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19890</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19890"/>
				<updated>2020-04-07T23:21:25Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19889</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19889"/>
				<updated>2020-04-07T23:20:06Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19888</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19888"/>
				<updated>2020-04-07T23:19:36Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19887 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19887</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19887"/>
				<updated>2020-04-07T23:18:56Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
= Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; Background&amp;amp;nbsp; =&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19886</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19886"/>
				<updated>2020-04-07T23:17:54Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19885 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19885</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19885"/>
				<updated>2020-04-07T23:17:32Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19884</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19884"/>
				<updated>2020-04-07T23:14:46Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Birth Outcomes Associated with Opioid Use During Pregnancy =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Infants exposed to opioids during pregnancy might be more likely to&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Be born preterm (born before 37 weeks of pregnancy); &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have poor fetal growth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Have longer hospital stays after birth;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Be re-hospitalized within 30 days of being born; and&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Possibly be born with birth defects.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
== Longer-Term Developmental Outcomes ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;There is limited information about longer-term outcomes of children exposed to opioids prenatally, including those with or without NAS. Not all babies exposed to opioids during pregnancy experience signs of NAS, but they may still have longer-term outcomes not obvious at birth. Results from a recent studyexternal icon suggest that children with NAS were more likely to have a developmental delay or speech or language impairment in early childhood, compared with children without NAS. It is not clear if these impacts are due to opioids specifically, other substance exposures, or other environmental influences. Findingsexternal icon about long-term outcomes of children exposed to opioids during pregnancy are inconsistent. More research is needed to better understand the spectrum of possible outcomes related to opioid exposure during pregnancy.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19883</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19883"/>
				<updated>2020-04-07T23:10:53Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Neonatal Abstinence Syndrome (NAS) =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Opioid use and medication assisted treatment for opioid use disorder during pregnancy can lead to neonatal abstinence syndrome (NAS) in some newborns. NAS is a group of conditions that can occur when newborns withdraw from certain substances including opioids that they were exposed to before birth. Withdrawal caused by opioids during the first 28 days of life is sometimes also called neonatal opioid withdrawal syndrome (NOWS). Withdrawal symptoms in newborns usually occur 48–72 hours after birth. Drug withdrawal symptoms may include:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Tremors (trembling) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Irritability, including excessive or high-pitched crying&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Sleep problems&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Hyperactive reflexes&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Seizures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Yawning, stuffy nose, or sneezing&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Poor feeding and sucking&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Vomiting&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Loose stools and dehydration&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Increased sweating&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The symptoms a newborn might experience, and how severe the symptoms will be, depend on different factors. Some factors include the type and amount of substance the newborn was exposed to before birth, the last time a substance was used, whether the baby is born full-term or premature, and if the newborn was exposed to more than one substance before birth.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19882</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19882"/>
				<updated>2020-04-07T23:06:35Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&lt;br /&gt;
== Opioid Use During Pregnancy ==&lt;br /&gt;
&amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon. There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome. The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19881</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19881"/>
				<updated>2020-04-07T23:03:57Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Overview&amp;amp;nbsp; =&lt;br /&gt;
&lt;br /&gt;
Opioid use during pregnancy can affect women and their babies. Women may use opioids as prescribed, may misuse prescription opioids, may use illicit opioids such as heroin, or may use opioids (opioid agonists and/or antagonists) as part of medication-assisted treatment for opioid use disorder. Regardless of the reason, women who use opioids during pregnancy should be aware of the possible risks during pregnancy, as well as her potential treatment options for opioid use disorder.&lt;br /&gt;
&amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid use in women aged 15–44 years has increased over time. This increase is similar to the dramatic increase in overall use in the United States. During 2008–2012, about 1 in 3 reproductive-aged women filled an opioid prescription each year. As such, opioid use during pregnancy is not uncommon.&amp;lt;br/&amp;gt; There have been significant increases in opioid use disorder during pregnancy. For example, the number of women with opioid use disorder at labor and delivery more than quadrupled from 1999 to 2014.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;Opioid exposure during pregnancy has been linked to some negative health effects for both mothers and their babies. These include maternal death and poor fetal growth, preterm birth, stillbirth, possible specific birth defects, and neonatal abstinence syndrome (see below). The effects of prenatal opioid exposure on children over time are largely unknown. However, using opioids as prescribed or for treatment of opioid use disorder during pregnancy may be necessary and outweigh the risks of these potential negative health outcomes.&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19880</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19880"/>
				<updated>2020-04-07T23:03:00Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19879 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19879</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19879"/>
				<updated>2020-04-07T23:00:50Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19878</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19878"/>
				<updated>2020-04-07T22:59:24Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19877</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19877"/>
				<updated>2020-04-07T22:59:07Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19876 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Scorecard Building =&lt;br /&gt;
&lt;br /&gt;
[[PO_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|Potential Objective Details]]&amp;lt;br/&amp;gt; [[PM_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|Potential Measures and Data Sources]]&amp;lt;br/&amp;gt; [[PA_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|Potential Actions and Partners]]&lt;br /&gt;
&lt;br /&gt;
= Resources to Investigate =&lt;br /&gt;
&lt;br /&gt;
[[RTI_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|More RTI on Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19876</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19876"/>
				<updated>2020-04-07T22:58:41Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19875</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19875"/>
				<updated>2020-04-07T22:54:51Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19874 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use]]&amp;lt;br/&amp;gt; Return to [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]] __TOC__&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; (Replace this text with the information you will place here.)&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; There is a need to [[Improve_Identification_&amp;amp;_Data_Collection_for_NAS|Improve Identifying and Data Collection on NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|TR - Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Scorecard Building =&lt;br /&gt;
&lt;br /&gt;
[[PO_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|Potential Objective Details]]&amp;lt;br/&amp;gt; [[PM_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|Potential Measures and Data Sources]]&amp;lt;br/&amp;gt; [[PA_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|Potential Actions and Partners]]&lt;br /&gt;
&lt;br /&gt;
= Resources to Investigate =&lt;br /&gt;
&lt;br /&gt;
[[RTI_-_Increase_Awareness_of_the_Risks_of_Opioid_Use_&amp;amp;_NAS|More RTI on Increase Awareness of the Risks of Opioid Use &amp;amp; NAS]]&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Public Awareness]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19874</id>
		<title>Increase Awareness of the Risks of Opioid Use &amp; NAS for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Increase_Awareness_of_the_Risks_of_Opioid_Use_%26_NAS_for_Mothers_with_SUDs&amp;diff=19874"/>
				<updated>2020-04-07T22:54:32Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19873</id>
		<title>Enhance Collaboration among Medical, Behavioral &amp; Social Services for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19873"/>
				<updated>2020-04-07T22:47:13Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to&amp;amp;nbsp;[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use&amp;amp;nbsp;]]&amp;lt;span style=&amp;quot;font-size: 13px;&amp;quot;&amp;gt;or &amp;lt;/span&amp;gt;[[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
__TOC__&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Collaborative practice between the dependency court, child welfare, substance use treatment, and other services systems offers a multitude of practical strategies and solutions to improve outcomes for child welfare involved families affected by substance use disorders. Collaborative practice results in a wider realm of resources to address the complex needs of families than is traditionally available through one system. Families present with complex needs that the child welfare system cannot address alone. For instance, children affected by trauma and pre-natal substance exposure often require interventions and treatment, in addition to substance abuse and mental health treatment provided to parents. Emphasis on treatment interventions and supports that focus only on children or parents separately, often result in fragmented and uncoordinated care. Collaborative policies and practices are required to provide access to family-centered interventions that can address the multiple needs of families. Evidence is now emerging that collaborative policy and practice positively influence five core outcomes, or the 5Rs, for families in the child welfare system impacted by substance use disorders &amp;lt;ref&amp;gt;https://ncsacw.samhsa.gov/files/Forum_Brief_FINAL_092314_reduced_508.pdf&amp;lt;/ref&amp;gt;:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Recovery: Parental recovery from substance use disorders &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Remain at Home: More children remain in the care of parents&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Reunification: Increased number and timeliness of parent-child reunification&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Recidivism: Decreased incidence of repeat maltreatment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Re-entry: Decrease in number of children re-entering out-of-home care&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
see Tools &amp;amp; Resources for training examples&lt;br /&gt;
&lt;br /&gt;
== Adoption and Safe Families Act ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;In 1997, the Adoption and Safe Families Act (ASFA) was enacted to address child welfare cases that lingered in the court system while parents cycled in and out of treatment. The legislation created a need to find effective responses to substance abuse and maltreatment within families. Five national reports followed addressing the co-occurring issues of parental substance abuse and child abuse and neglect &amp;lt;ref&amp;gt;https://ncsacw.samhsa.gov/files/Forum_Brief_FINAL_092314_reduced_508.pdf&amp;lt;/ref&amp;gt;. These reports are:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Responding to Alcohol and Other Drug Problems in Child Welfare: Weaving Together Practice and Policy (Child Welfare League of America, 1998) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Foster Care: Agencies Face Challenges Securing Stable Homes for Children of Substance Users (U.S. General Accounting Office, September 1998)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;No Safe Haven: Children of Substance-Abusing Parents (The National Center on Addiction and Substance Abuse at Columbia University, 1999)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Healing the Whole Family: A Look at Family Care Programs (Children’s Defense Fund, 1998)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Blending Perspectives and Building Common Ground: A Report to Congress on Substance Abuse and Child Protection (Dept. of Health and Human Services, 1999)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Models of Collaboration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Models of collaborative intervention vary widely in approach. They include innovative strategies such as &amp;lt;ref&amp;gt;https://ncsacw.samhsa.gov/files/Forum_Brief_FINAL_092314_reduced_508.pdf&amp;lt;/ref&amp;gt;:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;o-location of substance abuse specialists in child welfare offices or dependency courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Family Drug Courts or Dependency Drug Courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ollaborative case management and planning&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*D&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;evelopment of collaborative structures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*W&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;raparound services&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*I&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;mproved cross-system communication protocols&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ross-agency training of staff&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Project Nurture ==&lt;br /&gt;
&lt;br /&gt;
'''[http://www.healthshareoregon.org/transforming-health-together/care-innovations/maternal-child-and-family-wellness/project-nurture.html Project Nurture] - Health Share of Oregon'''&amp;lt;br/&amp;gt; ''Program Highlights (NUR)''&lt;br /&gt;
&lt;br /&gt;
*Team-based approach to prenatal care that includes prenatal clinician, addictions specialist, mental health support, case management, peer support and parenting resources &lt;br /&gt;
*Clinic and organizational leadership with program accountability and resources &lt;br /&gt;
*Transparent, standardized process for screening and monitoring for substance use and for DHS involvement &lt;br /&gt;
*Strong commitment to a planned, coordinated approach to the inpatient maternity stay, with protocols for pain management, DHS and social work involvement and discharge planning &lt;br /&gt;
*Extended postpartum support lasting a full year, with pediatric care integrated with the mother’s care, ongoing addiction support, and peer support for parenting &lt;br /&gt;
&lt;br /&gt;
''Outcomes Being Tracked''&lt;br /&gt;
&lt;br /&gt;
*Pre-term birth rates &lt;br /&gt;
*Cost Savings &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Collaboration_among_Medical,_Behavioral_&amp;amp;_Social_Services|TR - Enhance Collaboration among Medical, Behavioral &amp;amp; Social Services]]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19872</id>
		<title>Enhance Collaboration among Medical, Behavioral &amp; Social Services for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19872"/>
				<updated>2020-04-07T22:45:39Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to&amp;amp;nbsp;[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use&amp;amp;nbsp;]]&amp;lt;span style=&amp;quot;font-size: 13px;&amp;quot;&amp;gt;or &amp;lt;/span&amp;gt;[[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
__TOC__&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Collaborative practice between the dependency court, child welfare, substance use treatment, and other services systems offers a multitude of practical strategies and solutions to improve outcomes for child welfare involved families affected by substance use disorders. Collaborative practice results in a wider realm of resources to address the complex needs of families than is traditionally available through one system. Families present with complex needs that the child welfare system cannot address alone. For instance, children affected by trauma and pre-natal substance exposure often require interventions and treatment, in addition to substance abuse and mental health treatment provided to parents. Emphasis on treatment interventions and supports that focus only on children or parents separately, often result in fragmented and uncoordinated care. Collaborative policies and practices are required to provide access to family-centered interventions that can address the multiple needs of families. Evidence is now emerging that collaborative policy and practice positively influence five core outcomes, or the 5Rs, for families in the child welfare system impacted by substance use disorders:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Recovery: Parental recovery from substance use disorders &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Remain at Home: More children remain in the care of parents&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Reunification: Increased number and timeliness of parent-child reunification&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Recidivism: Decreased incidence of repeat maltreatment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Re-entry: Decrease in number of children re-entering out-of-home care&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
see Tools &amp;amp; Resources for training examples&lt;br /&gt;
&lt;br /&gt;
== Adoption and Safe Families Act ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;In 1997, the Adoption and Safe Families Act (ASFA) was enacted to address child welfare cases that lingered in the court system while parents cycled in and out of treatment. The legislation created a need to find effective responses to substance abuse and maltreatment within families. Five national reports followed addressing the co-occurring issues of parental substance abuse and child abuse and neglect. These reports are:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Responding to Alcohol and Other Drug Problems in Child Welfare: Weaving Together Practice and Policy (Child Welfare League of America, 1998) &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Foster Care: Agencies Face Challenges Securing Stable Homes for Children of Substance Users (U.S. General Accounting Office, September 1998)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;No Safe Haven: Children of Substance-Abusing Parents (The National Center on Addiction and Substance Abuse at Columbia University, 1999)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Healing the Whole Family: A Look at Family Care Programs (Children’s Defense Fund, 1998)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Blending Perspectives and Building Common Ground: A Report to Congress on Substance Abuse and Child Protection (Dept. of Health and Human Services, 1999)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Models of Collaboration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Models of collaborative intervention vary widely in approach. They include innovative strategies such as:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;o-location of substance abuse specialists in child welfare offices or dependency courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Family Drug Courts or Dependency Drug Courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ollaborative case management and planning&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*D&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;evelopment of collaborative structures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*W&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;raparound services&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*I&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;mproved cross-system communication protocols&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ross-agency training of staff&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Project Nurture ==&lt;br /&gt;
&lt;br /&gt;
'''[http://www.healthshareoregon.org/transforming-health-together/care-innovations/maternal-child-and-family-wellness/project-nurture.html Project Nurture] - Health Share of Oregon'''&amp;lt;br/&amp;gt; ''Program Highlights (NUR)''&lt;br /&gt;
&lt;br /&gt;
*Team-based approach to prenatal care that includes prenatal clinician, addictions specialist, mental health support, case management, peer support and parenting resources &lt;br /&gt;
*Clinic and organizational leadership with program accountability and resources &lt;br /&gt;
*Transparent, standardized process for screening and monitoring for substance use and for DHS involvement &lt;br /&gt;
*Strong commitment to a planned, coordinated approach to the inpatient maternity stay, with protocols for pain management, DHS and social work involvement and discharge planning &lt;br /&gt;
*Extended postpartum support lasting a full year, with pediatric care integrated with the mother’s care, ongoing addiction support, and peer support for parenting &lt;br /&gt;
&lt;br /&gt;
''Outcomes Being Tracked''&lt;br /&gt;
&lt;br /&gt;
*Pre-term birth rates &lt;br /&gt;
*Cost Savings &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Collaboration_among_Medical,_Behavioral_&amp;amp;_Social_Services|TR - Enhance Collaboration among Medical, Behavioral &amp;amp; Social Services]]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19871</id>
		<title>Enhance Collaboration among Medical, Behavioral &amp; Social Services for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19871"/>
				<updated>2020-04-07T22:37:42Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to&amp;amp;nbsp;[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use&amp;amp;nbsp;]]&amp;lt;span style=&amp;quot;font-size: 13px;&amp;quot;&amp;gt;or &amp;lt;/span&amp;gt;[[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
__TOC__&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Collaborative practice between the dependency court, child welfare, substance use treatment, and other services systems offers a multitude of practical strategies and solutions to improve outcomes for child welfare involved families affected by substance use disorders. Collaborative practice results in a wider realm of resources to address the complex needs of families than is traditionally available through one system. Families present with complex needs that the child welfare system cannot address alone. For instance, children affected by trauma and pre-natal substance exposure often require interventions and treatment, in addition to substance abuse and mental health treatment provided to parents. Emphasis on treatment interventions and supports that focus only on children or parents separately, often result in fragmented and uncoordinated care. Collaborative policies and practices are required to provide access to family-centered interventions that can address the multiple needs of families. Evidence is now emerging that collaborative policy and practice positively influence five core outcomes, or the 5Rs, for families in the child welfare system impacted by substance use disorders:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*Recovery: Parental recovery from substance use disorders &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Remain at Home: More children remain in the care of parents&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Reunification: Increased number and timeliness of parent-child reunification&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Recidivism: Decreased incidence of repeat maltreatment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Re-entry: Decrease in number of children re-entering out-of-home care&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; see Tools &amp;amp; Resources for training examples&lt;br /&gt;
&lt;br /&gt;
= Models of Collaboration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Models of collaborative intervention vary widely in approach. They include innovative strategies such as:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;o-location of substance abuse specialists in child welfare offices or dependency courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Family Drug Courts or Dependency Drug Courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ollaborative case management and planning&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*D&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;evelopment of collaborative structures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*W&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;raparound services&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*I&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;mproved cross-system communication protocols&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ross-agency training of staff&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Project Nurture ==&lt;br /&gt;
&lt;br /&gt;
'''[http://www.healthshareoregon.org/transforming-health-together/care-innovations/maternal-child-and-family-wellness/project-nurture.html Project Nurture] - Health Share of Oregon'''&amp;lt;br/&amp;gt; ''Program Highlights (NUR)''&lt;br /&gt;
&lt;br /&gt;
*Team-based approach to prenatal care that includes prenatal clinician, addictions specialist, mental health support, case management, peer support and parenting resources &lt;br /&gt;
*Clinic and organizational leadership with program accountability and resources &lt;br /&gt;
*Transparent, standardized process for screening and monitoring for substance use and for DHS involvement &lt;br /&gt;
*Strong commitment to a planned, coordinated approach to the inpatient maternity stay, with protocols for pain management, DHS and social work involvement and discharge planning &lt;br /&gt;
*Extended postpartum support lasting a full year, with pediatric care integrated with the mother’s care, ongoing addiction support, and peer support for parenting &lt;br /&gt;
&lt;br /&gt;
''Outcomes Being Tracked''&lt;br /&gt;
&lt;br /&gt;
*Pre-term birth rates &lt;br /&gt;
*Cost Savings &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Collaboration_among_Medical,_Behavioral_&amp;amp;_Social_Services|TR - Enhance Collaboration among Medical, Behavioral &amp;amp; Social Services]]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19870</id>
		<title>Enhance Collaboration among Medical, Behavioral &amp; Social Services for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19870"/>
				<updated>2020-04-07T22:35:11Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to&amp;amp;nbsp;[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use&amp;amp;nbsp;]]&amp;lt;span style=&amp;quot;font-size: 13px;&amp;quot;&amp;gt;or &amp;lt;/span&amp;gt;[[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
__TOC__&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Educating Providers =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; see Tools &amp;amp; Resources for training examples&lt;br /&gt;
&lt;br /&gt;
= Models of Collaboration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Models of collaborative intervention vary widely in approach. They include innovative strategies such as:&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;o-location of substance abuse specialists in child welfare offices or dependency courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Family Drug Courts or Dependency Drug Courts&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ollaborative case management and planning&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*D&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;evelopment of collaborative structures&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*W&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;raparound services&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*I&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;mproved cross-system communication protocols&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*C&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ross-agency training of staff&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Project Nurture ==&lt;br /&gt;
&lt;br /&gt;
'''[http://www.healthshareoregon.org/transforming-health-together/care-innovations/maternal-child-and-family-wellness/project-nurture.html Project Nurture] - Health Share of Oregon'''&amp;lt;br/&amp;gt; ''Program Highlights (NUR)''&lt;br /&gt;
&lt;br /&gt;
*Team-based approach to prenatal care that includes prenatal clinician, addictions specialist, mental health support, case management, peer support and parenting resources &lt;br /&gt;
*Clinic and organizational leadership with program accountability and resources &lt;br /&gt;
*Transparent, standardized process for screening and monitoring for substance use and for DHS involvement &lt;br /&gt;
*Strong commitment to a planned, coordinated approach to the inpatient maternity stay, with protocols for pain management, DHS and social work involvement and discharge planning &lt;br /&gt;
*Extended postpartum support lasting a full year, with pediatric care integrated with the mother’s care, ongoing addiction support, and peer support for parenting &lt;br /&gt;
&lt;br /&gt;
''Outcomes Being Tracked''&lt;br /&gt;
&lt;br /&gt;
*Pre-term birth rates &lt;br /&gt;
*Cost Savings &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Collaboration_among_Medical,_Behavioral_&amp;amp;_Social_Services|TR - Enhance Collaboration among Medical, Behavioral &amp;amp; Social Services]]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19869</id>
		<title>Enhance Collaboration among Medical, Behavioral &amp; Social Services for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19869"/>
				<updated>2020-04-07T22:33:31Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Undo revision 19868 by Dmt7109 (talk)&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to&amp;amp;nbsp;[[Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_During_Opioid_Use|Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use&amp;amp;nbsp;]]&amp;lt;span style=&amp;quot;font-size: 13px;&amp;quot;&amp;gt;or &amp;lt;/span&amp;gt;[[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|ZOOM MAP - Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy during Opioid Use]]&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
__TOC__&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Educating Providers =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; see Tools &amp;amp; Resources for training examples&lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== Project Nurture ==&lt;br /&gt;
&lt;br /&gt;
'''[http://www.healthshareoregon.org/transforming-health-together/care-innovations/maternal-child-and-family-wellness/project-nurture.html Project Nurture] - Health Share of Oregon'''&amp;lt;br/&amp;gt; ''Program Highlights (NUR)''&lt;br /&gt;
&lt;br /&gt;
*Team-based approach to prenatal care that includes prenatal clinician, addictions specialist, mental health support, case management, peer support and parenting resources &lt;br /&gt;
*Clinic and organizational leadership with program accountability and resources &lt;br /&gt;
*Transparent, standardized process for screening and monitoring for substance use and for DHS involvement &lt;br /&gt;
*Strong commitment to a planned, coordinated approach to the inpatient maternity stay, with protocols for pain management, DHS and social work involvement and discharge planning &lt;br /&gt;
*Extended postpartum support lasting a full year, with pediatric care integrated with the mother’s care, ongoing addiction support, and peer support for parenting &lt;br /&gt;
&lt;br /&gt;
''Outcomes Being Tracked''&lt;br /&gt;
&lt;br /&gt;
*Pre-term birth rates &lt;br /&gt;
*Cost Savings &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Collaboration_among_Medical,_Behavioral_&amp;amp;_Social_Services|TR - Enhance Collaboration among Medical, Behavioral &amp;amp; Social Services]]&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19868</id>
		<title>Enhance Collaboration among Medical, Behavioral &amp; Social Services for Mothers with SUDs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Collaboration_among_Medical,_Behavioral_%26_Social_Services_for_Mothers_with_SUDs&amp;diff=19868"/>
				<updated>2020-04-07T22:33:04Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: Replaced content with &amp;quot;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;parsererror xmlns=&amp;quot;http://www.mozilla.org/newlayout/xml/parsererror.xml&amp;quot;&amp;gt;XML Parsing Error: syntax error&amp;lt;/parsererror&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Steps_to_Minimize_Substance_Use_During_Pregnancy_or_Pregnancy_During_Substance_Use&amp;diff=19867</id>
		<title>Expand Steps to Minimize Substance Use During Pregnancy or Pregnancy During Substance Use</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Steps_to_Minimize_Substance_Use_During_Pregnancy_or_Pregnancy_During_Substance_Use&amp;diff=19867"/>
				<updated>2020-04-07T22:15:44Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;__NOTOC__ &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map&amp;amp;nbsp;or]] [[ZOOM_MAP_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy_or_Pregnancy_during_Opioid_Use|Zoom Map (Expand Steps to Minimize Opioid Use During Pregnancy or Pregnancy During Opioid Use)]]&amp;amp;nbsp;or [[ZOOM_MAP_-_Improve_Treatment_&amp;amp;_Enable_Recovery_for_People_with_SUDs|Zoom Map (Improve Treatment &amp;amp; Enable Recovery for People with SUDs)]]&amp;amp;nbsp;View [[Minimize_Babies_born_with_Opioid_Dependence|Minimize Babies Born with Opioid Addictions]] &amp;amp;nbsp;or&amp;amp;nbsp;[[ZOOM_MAP_-_Expand_Harm_Reduction_Practices_Associated_with_Opioid_Misuse|ZOOM MAP - Expand Harm Reduction Practices Associated with Opioid Misuse]]__TOC__&lt;br /&gt;
&lt;br /&gt;
= &amp;lt;span style=&amp;quot;color: #ed3900&amp;quot;&amp;gt;PRENATAL STRATEGIES&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
= Draft Driver Diagram =&lt;br /&gt;
&amp;lt;div class=&amp;quot;_&amp;quot;&amp;gt;The Public Health Foundation worked with the Department of Public Health at the University of Tennessee Knoxville to create a Driver Diagram for improving perinatal care and reducing Neonatal Abstinence Syndrome (NAS). This format is different from a strategy map, but has useful ideas that could be integrated into this strategy map template.&amp;lt;br/&amp;gt; [http://www.phf.org/resourcestools/Documents/TN%20NAS%20driver%20diagram%20Revised%2012-15-15.pdf [1]]&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot;&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Increase Access to Contraception =&lt;br /&gt;
&lt;br /&gt;
The National Preconception Health and Health Care Initiative provides educational resources to clinicians and their patients, and coordinates outreach and social media campaigns related to improving preconception health, including reducing substance use and treating substance use disorders before pregnancy.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Help Women Overcome Obstacles to Treatment, Family Planning and Prenatal Care =&lt;br /&gt;
&amp;lt;div class=&amp;quot;_&amp;quot;&amp;gt;Women who are misusing opioids or who have OUD may have many obstacles to getting treatment, family planning or prenatal care. A strategy to minimize unintentional pregnancies for these women should include plans to help them overcome obstacles to receiving these services. The obstacles include:&amp;lt;/div&amp;gt; &lt;br /&gt;
*Transportation &lt;br /&gt;
*Childcare &lt;br /&gt;
*Employment conflicts &lt;br /&gt;
*Unsupportive Living Environments &lt;br /&gt;
*Unstable Living Environments &lt;br /&gt;
*Homelessness &lt;br /&gt;
*Partner with a Substance Use Disorder &lt;br /&gt;
*Stigma and/or Guilt &lt;br /&gt;
*Fear of losing the child &lt;br /&gt;
*Fear of incarceration &lt;br /&gt;
*Fear of being discovered about misusing substances (by family, employer, etc.) &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools + Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Expand_Steps_to_Minimize_Opioid_Use_During_Pregnancy|TR - Expand Steps to Minimize Opioid Use During Pregnancy]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Treatment and Recovery]] [[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_%26_Expand_Screening_and_Testing_for_Misuse_and_Dependency&amp;diff=19866</id>
		<title>Improve &amp; Expand Screening and Testing for Misuse and Dependency</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_%26_Expand_Screening_and_Testing_for_Misuse_and_Dependency&amp;diff=19866"/>
				<updated>2020-04-07T22:13:20Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;Return to [[ZOOM_MAP_-_Increase_Early_Intervention_for_People_Misusing_Drugs|Zoom Map - Increase Early Interventions for People Misusing Drugs]] &lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
One of the keys for helping people get off the road of developing dependence and OUD is to do screening to detect the risks so that people who might be more likely to misuse are not prescribed opioids at all--or if they are, with added precautions. In other cases, some types of screening or testing can help identify people who are in the early stages of misusing opioids so they can get the type of intervention that will be most helpful before they develop an addiction. Doing more screening and better screening should be an important part of a comprehsnsive strategy.&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
== Screening for Risk Factors can Minimize People Misusing Opioids ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; Prescribing physicians or other medical professionals &amp;quot;should evaluate for mental health issues that can make patients vulnerable to addiction, says Hilary Connery, M.D., Ph.D., assistant professor of psychiatry at Harvard Medical School. “If you ignore screening for trauma, self-harm, and suicide,” she says, “you’re missing a crucial opportunity for prevention.”&amp;lt;ref&amp;gt;https://www.glamour.com/story/women-and-opioid-epidemic&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; A 2016 article in Health Psychology Open states that &amp;quot;Comprehensive screening and risk stratification are associated with decreased costs for patients, providers, and insurers as those prescribing are able to make increasingly well-informed decisions when treatment-planning regarding what to prescribe and how to best monitor patients for safety based on individual risk profiles.&amp;quot;&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193264/&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; Screening tools that provide risk stratification that can aid decisions on when additional toxicology testing, such as urine drug testing (UDT) is appropriate. &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Risk Factor Screening Tools ==&lt;br /&gt;
&lt;br /&gt;
There are a variety of risk factor screening tools that are appropriate for different scenarios.&amp;lt;br/&amp;gt; '''[http://interasolutions.com OARS]'''&amp;lt;br/&amp;gt; '''Opioid Abuse Risk Screener (OARS)''' was developed as a comprehensive self-administered measure of potential risk that includes a wide range of critical elements noted in the literature to be relevant to opioid risk.&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193264/&amp;lt;/ref&amp;gt;&amp;amp;nbsp;This 43-question assessment is administered using an iPad (tablet) and takes about 10 - 12 minutes to complete. It is HIPAA compliant, EMR supported, and has high reliability, validity and preditablity scores. The assessment is instantly scored and a report is available to the prescribing physician that provides a summary opioid risk profile and a multidimensional assessment of risk factors. The OARS also provides depression and anxiety scores that can be used for SBIRT assessments and wellness visits, including scores for the PHQ-9 and the GAD-7. All information is provided in a compressive easy to read report which clearly identifies aberrant behavior and risk factors for followup by the provider with the patient during the visit.&amp;lt;br/&amp;gt; &amp;amp;nbsp; The OARS is reimbursable with an average rate of $40/screening. Providers can get reimbursed in most cases with the CPT Code 96103 or the SBIRT codes while taking important steps to identify individuals that may be at risk for opioid misuse or abuse.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; InteraSolutions, the company that developed OARS, received a 2018 recipient of the State of Ohio's [https://www.usnews.com/news/best-states/ohio/articles/2018-09-12/ohio-set-to-award-latest-prizes-in-opioid-science-challenge Opioid Science Challenge] that seeks to identify and support scientific breakthroughs that help to address the opioid crisis. The OARS screening tool was recognized as one of those important breakthroughs.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;[[More_information_on_the_Opioid_Abuse_Risk_Screener|More information on the Opioid Abuse Risk Screener]] (OARS)&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''WellScreen'''&lt;br /&gt;
&lt;br /&gt;
[http://wellscreen.health/ WellScreen] integrates technology-based screening tools with the SBIRT model.&lt;br /&gt;
&lt;br /&gt;
== Key Benefits of Toxicology Testing for Misuse ==&lt;br /&gt;
&lt;br /&gt;
When done well, toxicology testing for misuse can contribute to addressing the opioid crisis in several ways:&lt;br /&gt;
&lt;br /&gt;
#It provides prescribing physicians with insights to reduce or eliminate prescriptions of opioids in situations where the risk of misuse is high. &lt;br /&gt;
#It quickly detects if opioids are being overused so steps to stop misuse can begin earlier. &lt;br /&gt;
#It detects if opioids are being underused and potentially diverted to illegal use (being sold or given away) or left around for possible theft. &lt;br /&gt;
#It enhances accountability and discourages people from misusing or diverting opioids because such behavior will be detected &lt;br /&gt;
&lt;br /&gt;
== Recommended Testing for People on Chronic Opioid Therapy ==&lt;br /&gt;
&lt;br /&gt;
Researchers estimate that 9.6–11.5 million adults, or approximately 3%–4% of the adult U.S. population, were prescribed long-term opioid therapy in 2005. &amp;lt;ref&amp;gt;https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm (See Citation 15)&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp; These people on chronic opioid therapy are at significant risk for developing Opioid Use Disorder, with one review of studies showing that an average of between 3% and 19% of people on chronic opioid therapy develop an addiction&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pubmed/25785523&amp;lt;/ref&amp;gt;&amp;amp;nbsp;.&amp;lt;br/&amp;gt; &amp;amp;nbsp; A review of 26 studies by Cochrane in 2010 concluded that well-screened patients receiving long-term opioid treatment were at very low risk of developing an addiction (&amp;lt; 1%)&amp;lt;ref&amp;gt;http://www.cochrane.org/CD006605/SYMPT_opioids-long-term-treatment-noncancer-pain&amp;lt;/ref&amp;gt;&amp;amp;nbsp;, but it should be considered that the studies they were reviewing may have been the ones funded by pharma companies trying to prove that long-term opioid treatment was safe, and the screening they used may have contributed to fewer instances of people becoming addicted--which itself could support the benefits of effective screening in reducing the risks of people becoming addicted.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; Prescriptions for this category of patients is a major contributor to the amount of opioids in the U.S. (statistics and citation needed). The following are recommended practices when people are on chronic opioid therapy:&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
#All patients should be assessed for risk factors, and then classified and stratified to optimize the testing protocols used. &lt;br /&gt;
#All patients on chronic opioid therapy should have a detailed treatment agreement in the form of a contract signed by both the patient and physician that clearly identifies risks and the terms under which opioids may be prescribed. &lt;br /&gt;
#Physicians must review PDMP data before prescribing opioids to identify possible risks or evidence of misuse or redirection. &lt;br /&gt;
#Drug screening (or preferably, toxicology testing) prior to the initiation of opioid therapy. &lt;br /&gt;
#Pill counts &lt;br /&gt;
#Screening to potentially make referrals to mental health providers or social service providers. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Current Status of Testing and Following Recommended Protocols =&lt;br /&gt;
&lt;br /&gt;
*Very few (statistics and source needed) physicians follow the recommended guidelines when giving prescriptions for people on chronic opioid therapy. &lt;br /&gt;
*Only 11 states make it mandatory for physicians to randomly test patients if they are writing multiple controlled substances prescriptions. &lt;br /&gt;
*Carol Falkowski, CEO of Drug Abuse Dialogs emphasized the need to expand testing and screening in doctors’ offices at the 2016 Saving Lives Opioid Conference in Minneapolis. &lt;br /&gt;
*Falkowski said that less then 5% of the referrals to treatment come from doctors’ offices, but they should be a huge source of referrals. &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Types of Urine Drug Testing =&lt;br /&gt;
&lt;br /&gt;
There are two categories of urine drug testing: screening and confirmatory.&amp;lt;br/&amp;gt; [[File:Testing comparison smaller.PNG|testing_comparison_smaller.PNG]]&amp;lt;br/&amp;gt; &amp;amp;nbsp; BB: Use the new cheek swab testing method as a key to changing that.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== SBIRT ==&lt;br /&gt;
&lt;br /&gt;
Screening is the first step to recognizing whether a person may have a substance use disorder. It is important to take clinical care a step further and get everyone the help they need. See the [[Expand_SBIRT_Program|SBIRT Program]] wiki page for more information. More information on [[Expand_SBIRT_Program|Expanding SBIRT Programs]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
== Other Programs and Services ==&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''[https://guidemed.com/ GuideMed]''' - This organization utilizes a software program to develop network standards of care for people receiving long-term opioid therapy for pain management, including:&lt;br /&gt;
&lt;br /&gt;
*Monitoring protocols &lt;br /&gt;
*Treatment recommendations &lt;br /&gt;
*Risk assessments &lt;br /&gt;
See this fact sheet for benefits and services offered &amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;[[File/view/GuideMed_Intro.pdf/615990097/GuideMed_Intro.pdf|[File:http://www.wikispaces.com/i/mime/32/application/pdf.png GuideMed_Intro.pdf]]] &amp;lt;div&amp;gt;[[File/view/GuideMed_Intro.pdf/615990097/GuideMed_Intro.pdf|GuideMed_Intro.pdf]] &lt;br /&gt;
*[[File/detail/GuideMed_Intro.pdf|Details]] &lt;br /&gt;
*[[File/view/GuideMed_Intro.pdf/615990097/GuideMed_Intro.pdf|Download]] &lt;br /&gt;
*463 KB &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; '''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Saliva Drug Screening&amp;lt;/span&amp;gt;'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;– For multiple reasons, a saliva sample should be chosen over the more common urine sample to test for drugs present in the system. Unlike urine, saliva tests cannot be adulterated, it can be administered rapidly, it has the ability to test for many things, it shows the metabolite drug and is cost-effective in the long run. Some healthcare systems may consider cost an issue, but saliva tests are billed to the same code.&amp;amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; ''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Contact&amp;lt;/span&amp;gt;''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;: John Cribbs (john@nodrugsneeded.com)&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; '''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Biobot Labs&amp;lt;/span&amp;gt;'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;- [http://biobot.io/ Biobot Labs] has built a robot which analyzes human waste to determine where drugs are being abused most in a particular city or town. They analyze human waste flowing through the sewers at various points throughout the system, testing for metabolized traces of various substances to pinpoint where the highest concentrations of opioid users -- or cocaine users, alcohol userse -- are located. The goal is to shift data collection and response away from overdose and death, and move it in the direction of early detection and overdose prevention.&amp;lt;/span&amp;gt; &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Improve_&amp;amp;_Expand_Screening_for_Risk_Factors_&amp;amp;_Testing_For_Misuse|TR - Improve &amp;amp; Expand Screening &amp;amp; Testing For Misuse]]&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| border=&amp;quot;1&amp;quot; class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:Pages with broken file links]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_%26_Expand_Screening_and_Testing_for_Misuse_and_Dependency&amp;diff=19865</id>
		<title>Improve &amp; Expand Screening and Testing for Misuse and Dependency</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Improve_%26_Expand_Screening_and_Testing_for_Misuse_and_Dependency&amp;diff=19865"/>
				<updated>2020-04-07T22:12:27Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;Return to [[ZOOM_MAP_-_Increase_Early_Intervention_for_People_Misusing_Drugs|Zoom Map - Increase Early Interventions for People Misusing Drugs]] &lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
One of the keys for helping people get off the road of developing dependence and OUD is to do screening to detect the risks so that people who might be more likely to misuse are not prescribed opioids at all--or if they are, with added precautions. In other cases, some types of screening or testing can help identify people who are in the early stages of misusing opioids so they can get the type of intervention that will be most helpful before they develop an addiction. Doing more screening and better screening should be an important part of a comprehsnsive strategy.&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
== Screening for Risk Factors can Minimize People Misusing Opioids ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; Prescribing physicians or other medical professionals &amp;quot;should evaluate for mental health issues that can make patients vulnerable to addiction, says Hilary Connery, M.D., Ph.D., assistant professor of psychiatry at Harvard Medical School. “If you ignore screening for trauma, self-harm, and suicide,” she says, “you’re missing a crucial opportunity for prevention.”&amp;lt;ref&amp;gt;https://www.glamour.com/story/women-and-opioid-epidemic&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; A 2016 article in Health Psychology Open states that &amp;quot;Comprehensive screening and risk stratification are associated with decreased costs for patients, providers, and insurers as those prescribing are able to make increasingly well-informed decisions when treatment-planning regarding what to prescribe and how to best monitor patients for safety based on individual risk profiles.&amp;quot;&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193264/&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; Screening tools that provide risk stratification that can aid decisions on when additional toxicology testing, such as urine drug testing (UDT) is appropriate. &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Risk Factor Screening Tools ==&lt;br /&gt;
&lt;br /&gt;
There are a variety of risk factor screening tools that are appropriate for different scenarios.&amp;lt;br/&amp;gt; '''[http://interasolutions.com OARS]'''&amp;lt;br/&amp;gt; '''Opioid Abuse Risk Screener (OARS)''' was developed as a comprehensive self-administered measure of potential risk that includes a wide range of critical elements noted in the literature to be relevant to opioid risk.&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193264/&amp;lt;/ref&amp;gt;&amp;amp;nbsp;This 43-question assessment is administered using an iPad (tablet) and takes about 10 - 12 minutes to complete. It is HIPAA compliant, EMR supported, and has high reliability, validity and preditablity scores. The assessment is instantly scored and a report is available to the prescribing physician that provides a summary opioid risk profile and a multidimensional assessment of risk factors. The OARS also provides depression and anxiety scores that can be used for SBIRT assessments and wellness visits, including scores for the PHQ-9 and the GAD-7. All information is provided in a compressive easy to read report which clearly identifies aberrant behavior and risk factors for followup by the provider with the patient during the visit.&amp;lt;br/&amp;gt; &amp;amp;nbsp; The OARS is reimbursable with an average rate of $40/screening. Providers can get reimbursed in most cases with the CPT Code 96103 or the SBIRT codes while taking important steps to identify individuals that may be at risk for opioid misuse or abuse.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; InteraSolutions, the company that developed OARS, received a 2018 recipient of the State of Ohio's [https://www.usnews.com/news/best-states/ohio/articles/2018-09-12/ohio-set-to-award-latest-prizes-in-opioid-science-challenge Opioid Science Challenge] that seeks to identify and support scientific breakthroughs that help to address the opioid crisis. The OARS screening tool was recognized as one of those important breakthroughs.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;[[More_information_on_the_Opioid_Abuse_Risk_Screener|More information on the Opioid Abuse Risk Screener]] (OARS)&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''WellScreen'''&lt;br /&gt;
&lt;br /&gt;
[http://wellscreen.health/ WellScreen] integrates technology-based screening tools with the SBIRT model.&lt;br /&gt;
&lt;br /&gt;
== Key Benefits of Toxicology Testing for Misuse ==&lt;br /&gt;
&lt;br /&gt;
When done well, toxicology testing for misuse can contribute to addressing the opioid crisis in several ways:&lt;br /&gt;
&lt;br /&gt;
#It provides prescribing physicians with insights to reduce or eliminate prescriptions of opioids in situations where the risk of misuse is high. &lt;br /&gt;
#It quickly detects if opioids are being overused so steps to stop misuse can begin earlier. &lt;br /&gt;
#It detects if opioids are being underused and potentially diverted to illegal use (being sold or given away) or left around for possible theft. &lt;br /&gt;
#It enhances accountability and discourages people from misusing or diverting opioids because such behavior will be detected &lt;br /&gt;
&lt;br /&gt;
== Recommended Testing for People on Chronic Opioid Therapy ==&lt;br /&gt;
&lt;br /&gt;
Researchers estimate that 9.6–11.5 million adults, or approximately 3%–4% of the adult U.S. population, were prescribed long-term opioid therapy in 2005. &amp;lt;ref&amp;gt;https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm (See Citation 15)&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp; These people on chronic opioid therapy are at significant risk for developing Opioid Use Disorder, with one review of studies showing that an average of between 3% and 19% of people on chronic opioid therapy develop an addiction&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pubmed/25785523&amp;lt;/ref&amp;gt;&amp;amp;nbsp;.&amp;lt;br/&amp;gt; &amp;amp;nbsp; A review of 26 studies by Cochrane in 2010 concluded that well-screened patients receiving long-term opioid treatment were at very low risk of developing an addiction (&amp;lt; 1%)&amp;lt;ref&amp;gt;http://www.cochrane.org/CD006605/SYMPT_opioids-long-term-treatment-noncancer-pain&amp;lt;/ref&amp;gt;&amp;amp;nbsp;, but it should be considered that the studies they were reviewing may have been the ones funded by pharma companies trying to prove that long-term opioid treatment was safe, and the screening they used may have contributed to fewer instances of people becoming addicted--which itself could support the benefits of effective screening in reducing the risks of people becoming addicted.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp; Prescriptions for this category of patients is a major contributor to the amount of opioids in the U.S. (statistics and citation needed). The following are recommended practices when people are on chronic opioid therapy:&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
#All patients should be assessed for risk factors, and then classified and stratified to optimize the testing protocols used. &lt;br /&gt;
#All patients on chronic opioid therapy should have a detailed treatment agreement in the form of a contract signed by both the patient and physician that clearly identifies risks and the terms under which opioids may be prescribed. &lt;br /&gt;
#Physicians must review PDMP data before prescribing opioids to identify possible risks or evidence of misuse or redirection. &lt;br /&gt;
#Drug screening (or preferably, toxicology testing) prior to the initiation of opioid therapy. &lt;br /&gt;
#Pill counts &lt;br /&gt;
#Screening to potentially make referrals to mental health providers or social service providers. &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Current Status of Testing and Following Recommended Protocols =&lt;br /&gt;
&lt;br /&gt;
*Very few (statistics and source needed) physicians follow the recommended guidelines when giving prescriptions for people on chronic opioid therapy. &lt;br /&gt;
*Only 11 states make it mandatory for physicians to randomly test patients if they are writing multiple controlled substances prescriptions. &lt;br /&gt;
*Carol Falkowski, CEO of Drug Abuse Dialogs emphasized the need to expand testing and screening in doctors’ offices at the 2016 Saving Lives Opioid Conference in Minneapolis. &lt;br /&gt;
*Falkowski said that less then 5% of the referrals to treatment come from doctors’ offices, but they should be a huge source of referrals. &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Types of Urine Drug Testing =&lt;br /&gt;
&lt;br /&gt;
There are two categories of urine drug testing: screening and confirmatory.&amp;lt;br/&amp;gt; [[File:Testing comparison smaller.PNG|testing_comparison_smaller.PNG]]&amp;lt;br/&amp;gt; &amp;amp;nbsp; BB: Use the new cheek swab testing method as a key to changing that.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Promising Programs =&lt;br /&gt;
&lt;br /&gt;
== SBIRT ==&lt;br /&gt;
&lt;br /&gt;
Screening is the first step to recognizing whether a person may have a substance use disorder. It is important to take clinical care a step further and get everyone the help they need. See the [[Expand_SBIRT_Program|SBIRT Program]] wiki page for more information. More information on [[Expand_SBIRT_Program|Expanding SBIRT Programs]]&lt;br /&gt;
&lt;br /&gt;
== Other Programs and Services ==&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''[https://guidemed.com/ GuideMed]''' - This organization utilizes a software program to develop network standards of care for people receiving long-term opioid therapy for pain management, including:&lt;br /&gt;
&lt;br /&gt;
*Monitoring protocols &lt;br /&gt;
*Treatment recommendations &lt;br /&gt;
*Risk assessments &lt;br /&gt;
See this fact sheet for benefits and services offered &amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;[[File/view/GuideMed_Intro.pdf/615990097/GuideMed_Intro.pdf|[File:http://www.wikispaces.com/i/mime/32/application/pdf.png GuideMed_Intro.pdf]]] &amp;lt;div&amp;gt;[[File/view/GuideMed_Intro.pdf/615990097/GuideMed_Intro.pdf|GuideMed_Intro.pdf]] &lt;br /&gt;
*[[File/detail/GuideMed_Intro.pdf|Details]] &lt;br /&gt;
*[[File/view/GuideMed_Intro.pdf/615990097/GuideMed_Intro.pdf|Download]] &lt;br /&gt;
*463 KB &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; '''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Saliva Drug Screening&amp;lt;/span&amp;gt;'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;– For multiple reasons, a saliva sample should be chosen over the more common urine sample to test for drugs present in the system. Unlike urine, saliva tests cannot be adulterated, it can be administered rapidly, it has the ability to test for many things, it shows the metabolite drug and is cost-effective in the long run. Some healthcare systems may consider cost an issue, but saliva tests are billed to the same code. &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000&amp;quot;&amp;gt;[citation needed] Review this to learn more: &amp;lt;/span&amp;gt;[https://vimeo.com/160404196 [1]] &amp;lt;span style=&amp;quot;color: #f40b2c&amp;quot;&amp;gt;and then delete the link to the discussion&amp;lt;/span&amp;gt;.&amp;lt;br/&amp;gt; ''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Contact&amp;lt;/span&amp;gt;''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;: John Cribbs (john@nodrugsneeded.com)&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; '''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Biobot Labs&amp;lt;/span&amp;gt;'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;- [http://biobot.io/ Biobot Labs] has built a robot which analyzes human waste to determine where drugs are being abused most in a particular city or town. They analyze human waste flowing through the sewers at various points throughout the system, testing for metabolized traces of various substances to pinpoint where the highest concentrations of opioid users -- or cocaine users, alcohol userse -- are located. The goal is to shift data collection and response away from overdose and death, and move it in the direction of early detection and overdose prevention.&amp;lt;/span&amp;gt; &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Improve_&amp;amp;_Expand_Screening_for_Risk_Factors_&amp;amp;_Testing_For_Misuse|TR - Improve &amp;amp; Expand Screening &amp;amp; Testing For Misuse]]&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| border=&amp;quot;1&amp;quot; class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:Pages with broken file links]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Disrupt_the_Supply_of_Illegal_Drugs&amp;diff=19864</id>
		<title>Disrupt the Supply of Illegal Drugs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Disrupt_the_Supply_of_Illegal_Drugs&amp;diff=19864"/>
				<updated>2020-04-07T22:09:06Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;font-size: 13px;&amp;quot;&amp;gt;or &amp;lt;/span&amp;gt;[[ZOOM_MAP_-_Reduce_Access_to_Opioids|Zoom Map (Reduce Access to Opioids)]] &lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
Add a intro paragraph here. &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
Key to any strategy to reduce opioid misuse is preventing illicit opioids, including heroin and synthetic opioids, from ever reaching communities. This role is almost exclusively the role and responsiblity of law enforcement at both the federal and state level, and requires cooperation between jurisdictions and federal partners to ensure success.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;In the United States, fentanyl is classified as a Schedule II controlled substance, meaning there is a potential for misuse and dependence, but it does have an accepted medical use and can be prescribed for restricted use. Although prescribed synthetic opioids are sometimes diverted to the illicit market, the main reason for the surge in high purity synthetic opioids are from the increase in manufacturing from clandestine labs, which are either pressed into pills or left in powder form and mixed with heroin.&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;Drug Policy&amp;quot;&amp;gt;https://drugpolicy.org/drug-facts/are-synthetic-opioids-legal&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Law Enforcement, State, and Federal Response&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Increasing seizures of synthetic opioid-laced heroin by law enforcement, calls from politicians to increase punishment for possession and/or sale of illicit fentanyl included escalating mandatory minimum sentencing, and even capital punishment for sale of heroin.There is no evidence that escalating criminal punishment will have any effect on reducing risk of overdose or use in general. Research has suggested that these policies will fail to address the issues involving fentanyl and will continue the harmful trend of mass incarceration in the US.&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;Drug Policy&amp;quot;&amp;gt;https://drugpolicy.org/drug-facts/are-synthetic-opioids-legal&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Individual states and the federal government’s efforts are centered around placing individual synthetic opioids and opiate-like NPS into Schedule I of the Controlled Substances Act (CSA).&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;Drug Policy&amp;quot;&amp;gt;https://drugpolicy.org/drug-facts/are-synthetic-opioids-legal&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
== Perceived Dangers of Accidental Overdoses ==&lt;br /&gt;
&lt;br /&gt;
With the distribution of [[Additional_Info_on_Fentanyl|fentanyl]], a powerful opioid that can be lethal in small amounts,&amp;amp;nbsp;overdoses have been reported by law enforment personnel as having&amp;amp;nbsp;occured&amp;amp;nbsp;through inhalation&amp;amp;nbsp;or absorption&amp;amp;nbsp;through the skin during routine encounters.&amp;lt;ref&amp;gt;http://www.cnn.com/2017/05/16/health/police-fentanyl-overdose-trnd/?iid=ob_article_footer_expansion]&amp;lt;/ref&amp;gt;&amp;amp;nbsp;These instances, however, are more myth than reality,&amp;lt;ref&amp;gt;_&amp;lt;/ref&amp;gt; and can lead to misplaced fear when law enforement and emergency responders come upon a suspected overdose. Any delay in responding to an overdose could cause brain damage and even death.&lt;br /&gt;
See page on [[Support_Strategies_to_Address_Fentanyl|Support Strategies to Address Fentanyl]]&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
= National Programs =&lt;br /&gt;
&lt;br /&gt;
== DEA 360 Strategy ==&lt;br /&gt;
&lt;br /&gt;
'''Target Drug Trafficking Organizations'''&amp;lt;br/&amp;gt; In the past, the DEA has targeted low-level, first time non-violent offenders who usually are selling to get high themselves.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[6]&amp;lt;/sup&amp;gt; This new strategy will target all drug deals, but start from the top down.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[7]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;quot;''These drug trafficking organizations are predators. There's no other way to describe it. They look for the vulnerable, they exploit them by finding them while they are trying to get treatment; that's how severe, how bad these drug trafficking organizations are to find their customer and peddle their poison. We're going to put together a task force and this task force is going to put together building federal cases based on these overdoses, and there is significant sentencing around and this is a way to impact straight into the organization and take out upper level members of an organization that directly impact the flow of drugs''.”&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[8]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; -Thomas Gorman, Assistant Special Agent in Charge, DEA&lt;br /&gt;
&lt;br /&gt;
== Organized Crime Drug Enforcement Task Force ==&lt;br /&gt;
&lt;br /&gt;
'''Organized Crime Drug Enforcement Task Force (OCTDEF) National Heroin/Fentanyl and Opioid Initiative'''&amp;lt;br/&amp;gt; Since its inception in December of 2014, the ultimate goal of this initiative has been to develop multi-agency, multi-jurisdictional cases against criminal organizations. The Initiative leverages the national structure, resources and information sharing capabilities to identify the local street level distributors who are responsible for overdose deaths, as well as their network of suppliers at the local and regional level. In the last several years, OCDETF investigators and prosecutors attacked the opioid epidemic by prosecuting rogue physicians, pharmacists, internet sales, and pill mill operations. Their traditional diversion investigations involved overwriting of oxycodone by doctors, and misuse of fentanyl patches by users who clipped the edges to consume the gel inside. Today, OCTDEF funds 60 Heroin/Fentanyl and Opioid Initiatives across the country. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[9]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; '''Working With China to Stop Export of Controlled Substances'''&lt;br /&gt;
&lt;br /&gt;
*A large number of synthetic opioids, specifically fentanyl, come to the US from China. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[10]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*China has agreed to crack down on the exports of substances that are controlled in the US, but not in China.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[11]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*The US and China will work together to exchange more law enforcement and scientific information to coordinate actions.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[12]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*Cooperation between the U.S. Drug Enforcement Agency (DEA) and the China Ministry of Public Security (MPS) and recognized China’s actions toward combating global synthetic drug trafficking.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[13]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*On October 1, 2015, China took an important step in international coordination by controlling a list of 116 synthetic drugs that were widely abused in the U.S.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[14]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*When evaluating a substance for control, the new provision also allows China to consider harm to the public in countries other than China.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[15]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*DEA continues to share information with Chinese officials to secure scheduling of additional fentanyl-class substances in China due to the wave of recent deaths in the United States from these synthetic opioids. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[16]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*At a time of massive growth in postal shipments from China due to e-commerce, the investigators found that the postal system received the electronic data on just over a third of all international packages, making more than 300 million packages in 2017 much harder to screen. Data in the Senate report shows no significant improvement during 2017 despite the urgency. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[17]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*The U.S. Postal Service said it has made dramatic progress in the last year in total packages with opioids seized by U.S. Customs and Border Protection... implementing the use of electronic data is slowed by the need to negotiate with international partners, but the service is making progress. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[18]&amp;lt;/sup&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= General Strategies =&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Better Addiction Prevention, Treatment, and Recovery Services&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Improve access to prevention, treatment, and recovery support services to prevent the health, social, and economic consequences associated with opioid misuse and addiction, and to enable individuals to achieve long-term recovery.&amp;lt;ref name=&amp;quot;HHS&amp;quot;&amp;gt;https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf&amp;lt;/ref&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;br/&amp;gt; &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Better Data&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Strengthen public health data reporting and collection to improve the timeliness and specificity of data, and to inform a real-time public health response as the epidemic evolves.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;HHS&amp;quot;&amp;gt;https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;br/&amp;gt; &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Better Pain Management&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Advance the practice of pain management to enable access to high-quality, evidence-based pain care that reduces the burden of pain for individuals, families, and society while also reducing the inappropriate use of opioids and opioid-related harms.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;HHS&amp;quot;&amp;gt;https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Better Targeting of Overdose Reversing Drugs&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Target the availability and distribution of overdose-reversing medications to ensure the broad provision of these drugs to people likely to experience or respond to an overdose, with a particular focus on targeting high-risk populations.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;HHS&amp;quot;&amp;gt;https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Better Research&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Support cutting-edge research that advances our understanding of pain, overdose and addiction, leads to the development of new treatments, and identifies effective public health interventions to reduce opioid-related health harms.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;HHS&amp;quot;&amp;gt;https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Expand_Efforts_to_Disrupt_the_Supply_of_Heroin_&amp;amp;_Synthetic_Opioids_to_the_Community|TR - Expand Efforts to Disrupt the Supply of Heroin &amp;amp; Synthetic Opioids to the Community]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2016/hq061016.shtml [https://www.dea.gov/press-releases/2016/06/10/dea-warning-police-and-public-fentanyl-exposure-kills]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2016/hq061016.shtml [2]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2016/hq061016.shtml [3]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2016/hq061016.shtml [4]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2016/hq061016.shtml [5]] &lt;br /&gt;
#[http://www.wdrb.com/story/33150219/dea-announces-new-strategy-to-stop-drug-trafficking-drug-violence-and-drug-abuse [6]] &lt;br /&gt;
#[http://www.wdrb.com/story/33150219/dea-announces-new-strategy-to-stop-drug-trafficking-drug-violence-and-drug-abuse [7]] &lt;br /&gt;
#[http://www.wdrb.com/story/33150219/dea-announces-new-strategy-to-stop-drug-trafficking-drug-violence-and-drug-abuse [8]] &lt;br /&gt;
#[https://www.justice.gov/usao/file/895091/download [9]] &lt;br /&gt;
#[https://www.statnews.com/2016/09/03/us-china-fentanyl/ [10]] &lt;br /&gt;
#[https://www.statnews.com/2016/09/03/us-china-fentanyl/ [11]] &lt;br /&gt;
#[https://www.statnews.com/2016/09/03/us-china-fentanyl/ [12]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2017/hq011317.shtml [13]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2017/hq011317.shtml [14]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2017/hq011317.shtml [15]] &lt;br /&gt;
#[https://www.dea.gov/divisions/hq/2017/hq011317.shtml [16]] &lt;br /&gt;
##&lt;br /&gt;
##*&lt;br /&gt;
##**&lt;br /&gt;
##***&lt;br /&gt;
##****&lt;br /&gt;
##*****&lt;br /&gt;
##******&lt;br /&gt;
##*******[http://time.com/5117820/china-opioids-postal-service-drugs/ [17]] &lt;br /&gt;
##*******[http://time.com/5117820/china-opioids-postal-service-drugs/ [18]]                 &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Reduce_Non-Medical_Access_to_Prescription_Drugs&amp;diff=19863</id>
		<title>Reduce Non-Medical Access to Prescription Drugs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Reduce_Non-Medical_Access_to_Prescription_Drugs&amp;diff=19863"/>
				<updated>2020-04-07T22:03:05Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
''Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Reduce_Access_to_Opioids|Zoom Map (Reduce Access to Opioids)]]''&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
To minimize diversion, it is essential that people who have prescription medications in their homes store them safely.&amp;amp;nbsp; When people begin to misuse prescription drugs, they often acquire them by stealing them from family, relatives, friends or from homes that they enter for other reasons (work, open houses, breaking and entering).&amp;amp;nbsp; If prescription drugs are safely stored, misuse can be stopped earlier, because people who have not yet developed a dependence on opioids usually do not go directly to illegal opioids like heroin or fentanyl.&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;__TOC__Prescription drugs that are not safely stored can also be accidentally taken by young children or by curious pre-teens.&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
Safe storage of prescription drugs within the home has been identified as key priority strategy by many organizations and coalitions.&amp;lt;ref&amp;gt;https://www.end-opioid-epidemic.org/storage-and-disposal/&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;http://www.rxsafetymatters.org/families-and-communities/safe-storage-and-disposal/&amp;lt;/ref&amp;gt;&amp;amp;nbsp; Even if a community does an excellent job of reducing prescriptions and taking back or disposing of unused opioids, there will still be a lot of opioids in communities. Researchers estimated that in 2005, 3-4% of people were being prescribed opioids for chronic pain&amp;lt;ref&amp;gt;https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm&amp;lt;/ref&amp;gt;&amp;amp;nbsp;&amp;lt;span style=&amp;quot;font-size: 13px;&amp;quot;&amp;gt;and many others are legitimately being prescribed opioids for short-term pain management, and many others who are prescribed other drugs that can be misused, stolen or accidentally consumed by children.&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Failure to securely store prescription drugs contributes to the opioid epidemic and other health hazards in several ways.&lt;br /&gt;
&lt;br /&gt;
#Easy access to prescription drugs can lead to initial experimentation, especially by teens.&amp;lt;ref&amp;gt;http://makeitasafehome.org/the-problem/&amp;lt;/ref&amp;gt; &lt;br /&gt;
#Stealing prescription drugs, which is much easier when they are commonly available in unlocked medicine cabinets, is often a step toward more destructive misuse. &lt;br /&gt;
#Easy access to unsecured opioids or other prescription drugs contributes to theft by people who sell them or give them away. &lt;br /&gt;
#Children who access unsecured drugs sometimes take them, thinking they are candy. &lt;br /&gt;
&lt;br /&gt;
= Staggering Statistics =&lt;br /&gt;
&lt;br /&gt;
*Only 2 in 10 who have dangerous medications—such as opioid pain pills, stimulants used to treat ADHD, and sedatives—lock them up &lt;br /&gt;
*Nearly 70% of prescription opioid medications kept in homes with children are not stored safely&amp;lt;ref&amp;gt;https://www.jhsph.edu/news/news-releases/2017/majority-of-opioid-medications-not-safely-stored-in-home-with-children-survey-finds.html&amp;lt;/ref&amp;gt; &lt;br /&gt;
*A recent study of adults living in households with children, prescription opioids were stored in a locked or latched place in only 32.6% of households with young children and 11.7% with older children.&amp;lt;ref&amp;gt;https://pediatrics.aappublications.org/content/139/3/e20162161&amp;lt;/ref&amp;gt; &lt;br /&gt;
*More than 1,600 teens begin abusing prescription drugs each day.&amp;lt;ref&amp;gt;http://www.rxsafetymatters.org/families-and-communities/facts-and-figures/&amp;lt;/ref&amp;gt; &lt;br /&gt;
*Almost 1 in every 4 teens in America say they have misused or abused a prescription drug.&amp;lt;ref&amp;gt;http://www.rxsafetymatters.org/families-and-communities/facts-and-figures/&amp;lt;/ref&amp;gt; &lt;br /&gt;
*60,000 kids under the age of 5 accidentally ingest these dangerous drugs every year and wind up in emergency rooms, according to data from the CDC&amp;lt;ref&amp;gt;http://www.consumerreports.org/drugs/best-ways-to-protect-kids-accidental-drug-poisoning-/&amp;lt;/ref&amp;gt; &lt;br /&gt;
*12-17 year olds abuse prescription drugs more than ecstasy, heroin, crack/cocaine and methamphetamines combined.&amp;lt;ref&amp;gt;http://www.rxsafetymatters.org/families-and-communities/facts-and-figures/&amp;lt;/ref&amp;gt; &lt;br /&gt;
*In one study, respondents reported storing their opioid medication in a locked (8.6%) or latched (20.9%) location.&amp;lt;ref&amp;gt;Kennedy-Hendricks A, et al. “Medication sharing, storage and disposal practices for opioid medications among US adults.” JAMA Intern Med 2016; 176:1027-29.&amp;lt;/ref&amp;gt; &lt;br /&gt;
*San Diego's SafeHomes Coalition reports that more than 70% of misused prescription drugs come from someone's medicine cabinet, not from a dealer on the street. &amp;lt;ref&amp;gt;http://makeitasafehome.org/the-problem/&amp;lt;/ref&amp;gt; &lt;br /&gt;
*The National Drug Intelligence Center reported that $184 million in prescription drug thefts occurred in 2010—a 350 percent increase since 2007&amp;lt;ref&amp;gt;https://www.nnw.org/publication/medication-theft-protecting-our-most-vulnerable-neighbors&amp;lt;/ref&amp;gt;. &amp;amp;nbsp;They note that older people are especially vulnerable to theft of prescription drugs. &lt;br /&gt;
*Over half of teens, ages 12 and up, obtained prescription drugs from a friend or family member &amp;quot;for free&amp;quot; &lt;br /&gt;
&lt;br /&gt;
= Programs to Encourage Safe Storage and Reduce the Theft of Prescription Drugs =&lt;br /&gt;
&lt;br /&gt;
== Examples of Campaigns and Organzations Supporting Safe Storage ==&lt;br /&gt;
&lt;br /&gt;
'''Safe Homes Coalition'''&amp;lt;br/&amp;gt; [http://makeitasafehome.org/ SafeHomes Coalition] helps communities start programs to raise awareness of the proper use, storage and disposal of prescription drugs. (They can help your community start a chapter.) This [https://www.youtube.com/watch?v=m7C01hibtBg&amp;amp;feature=youtu.be SafeHomes PSA] provides more information.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; '''Up and Away Campaign'''&amp;lt;br/&amp;gt; This [http://www.upandaway.org/#about campaign] is designed to remind families about the importance of safe medicine storage. See [[TR_-_Improve_Safe_Storage_of_Prescription_Drugs|Tools &amp;amp; Resources]] for resources to distribute in your community.&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Launching Community-wide Collaborative Campaigns ==&lt;br /&gt;
&lt;br /&gt;
=== Drug Disposal and Safe Storage Campaign ===&lt;br /&gt;
&lt;br /&gt;
Many communities have done some education and awareness efforts to increase prescription drug disposal and safe storage, but there is potential to reach significantly more people by engaging a diverse group of cross-sector partners in a campaign.&lt;br /&gt;
&lt;br /&gt;
'''See Details:&amp;amp;nbsp;&amp;amp;nbsp;'''[[Community_Safe_Storage_Campaign|Collaborative campaign to increase safe storage and prescription drug disposal]].&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
=== Self-Funding Program for Safe Storage Caps (TimerCaps) ===&lt;br /&gt;
&lt;br /&gt;
A local coalition, hospital, insurance company or non-profit can sponsor a program to distribute TimerCaps to people using prescription drugs. Sponsors have their logo imprinted on the cap and the label and can give them away at community events or via partners like pharmacists, community groups for seniors, or the prescribing doctors.&lt;br /&gt;
&lt;br /&gt;
'''See Details:'''&amp;amp;nbsp;[[Details_for_a_Self-Funding_Safe_Storage_campaign|Self-Funding Safe Storage campaign]].&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''Case Study of Successful Coalition Campaign with TimerCaps'''&lt;br /&gt;
South Kingston Program for Prevention and Rebels Inspiring Positive Lifestyles joined forces to raise funds to send youth leaders to CADCA training. The coalition held community awareness events and garnered local news publicity for their cause. For further details, see &amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Safe Storage Products =&lt;br /&gt;
&amp;lt;div class=&amp;quot;_&amp;quot;&amp;gt;Below are list of products that can either be distributed within your community or advertised by community coalitions for families to purchase.&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot;&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &lt;br /&gt;
== TimerCaps ==&lt;br /&gt;
&lt;br /&gt;
[[File:Orange-TimerCap.jpg|Orange-TimerCap.jpg]]&amp;lt;br/&amp;gt; [https://timercap.com/ TimerCap] has a built-in LCD stopwatch timer. Like a stopwatch, the display on the cap counts-up, first the seconds, then minutes and hours since the cap was replaced.&amp;lt;br/&amp;gt; Timer caps come in different sizes, and they can replace an existing medicine bottle cap (or you can get a cap and bottle combination). Using a TimerCap helps accomplish all [[Six_principles_of_prescription_abuse_prevention|six principles of prescription abuse prevention]]. TimerCaps are easy to use and don't require a change in patient behavior.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; '''Improve Patient Safety'''&lt;br /&gt;
&lt;br /&gt;
*Provide the PEACE OF MIND of knowing they did or did not take their medication. &lt;br /&gt;
*Help seniors avoid accidental overdoses and emergency room visits due to accidentally taking medications multiple times. &lt;br /&gt;
*Easily know how long it has been since taking medication (to check before driving) &lt;br /&gt;
*Tracker form to help monitor their intake and pain levels or other information &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; '''Deter Theft of Pills'''&lt;br /&gt;
&lt;br /&gt;
*Easily detect unwanted openings to the exact minute it happened &lt;br /&gt;
*Deters kids or neighbors from sneaking a few pills--as they would be caught by the new time &lt;br /&gt;
*Solution to measure, monitor, manage, detect,and deter opioids abuse. &lt;br /&gt;
&amp;lt;br/&amp;gt; '''Economical Enough to Give Away at Events or by Partners'''&amp;lt;br/&amp;gt; TimerCaps are a low-cost option for improving safe storage (as low as $2.49 each), so they are economical as a give-away at educational events, or they can be given to people by community partners. Since the TimerCap lids and labels can be customized with a logo or other branding information, sponsors who make donations to fund the program receive valuable recognition for their support. See coalition testimonials: &amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;[[File/view/Testimonials.pages/628136277/Testimonials.pages|[File:http://www.wikispaces.com/i/mime/32/empty.png Testimonials.pages]]] &amp;lt;div&amp;gt;[[File/view/Testimonials.pages/628136277/Testimonials.pages|Testimonials.pages]] &lt;br /&gt;
*[[File/detail/Testimonials.pages|Details]] &lt;br /&gt;
*[[File/view/Testimonials.pages/628136277/Testimonials.pages|Download]] &lt;br /&gt;
*743 KB &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; Visit [http://www.timercap.com www.timercap.com] or Contact: 800-557-4072 ext. 106&amp;lt;br/&amp;gt; &amp;amp;nbsp; &lt;br /&gt;
== Locking Storage Devices ==&lt;br /&gt;
&lt;br /&gt;
'''Ikeyp'''&amp;lt;br/&amp;gt; [[File:Ikeyp Product.png|Ikeyp Product.png]]&amp;lt;br/&amp;gt; The world's first smart storage device for personal items that need to be securely stored yet regularly accessed. See [https://ikeyp.com/ website] for a comprehensive list of uses and products.&amp;lt;br/&amp;gt; Introductory video from a tech review: [https://vimeo.com/184531456 [1]]&amp;lt;br/&amp;gt; Gadgetgram Review including a video created by the manufacture of the product for CES 2018: [http://www.gadgetgram.com/2017/12/27/ikeyp-pro-smart-safe/ [2]]&amp;lt;br/&amp;gt; Retail price is $149.00 but a coordinated community-wide effort to promote safe storage of prescription drugs, bulk purchase discounts may be available.&amp;lt;br/&amp;gt; ''Contact for bulk purchasing'': 1-800-485-8904&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;color: #67677e; font-size: 1.2em; letter-spacing: 0.5px&amp;quot;&amp;gt;'''Lockable Caps'''&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; '''Safer Lock'''&amp;lt;br/&amp;gt; [[File:Safer Lock Product.png|Safer Lock Product.png]]&amp;lt;br/&amp;gt; [https://saferlockrx.com/ Safer Lock] is a patented 4-digit combination locking cap. This could be purchased by communities at wholesale prices and distributed to community members at lower prices.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; Products:&lt;br /&gt;
&lt;br /&gt;
#[https://saferlockrx.com/product/safer-lock/ Safer Lock] &lt;br /&gt;
#[https://saferlockrx.com/product/medication-lock-box/ Safer Lock Box] &lt;br /&gt;
#[https://saferlockrx.com/product/safer-lock-cases/ Safer Lock Multi-Packs &amp;amp; Case]s &lt;br /&gt;
#[https://saferlockrx.com/product/book-safe/ Book Safe] &lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; ''Contact for wholesale pricing'': (844) 209-5044&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Changing Drug Packaging ==&lt;br /&gt;
&lt;br /&gt;
*Packaging opioid drugs in [https://en.wikipedia.org/wiki/Blister_pack blister packs] , or in single-dose packages, instead of having an entire bottle filled with prescription pills have been shown to help prevent accident poisonings in children&amp;lt;ref&amp;gt;http://www.livescience.com/58351-kids-opioids-ingestion.html&amp;lt;/ref&amp;gt; &lt;br /&gt;
*One vendor of Single-dose packets is [https://pack4u.com/ Pack4U]. They provide a sophisticated, personalized option that allows pharmacies to deliver higher value to patients needing any prescriptions, including opioids. &lt;br /&gt;
&lt;br /&gt;
= Education Topics =&lt;br /&gt;
&lt;br /&gt;
== Educate Parents on Key Points ==&lt;br /&gt;
&lt;br /&gt;
*The most secure way to keep prescription medications is in a locked storage box up and away &lt;br /&gt;
*If locking them is not an option keep them stored in a secured place in your home that is up and away from children. &lt;br /&gt;
*Keep a medication log so you know what medications you have and how many you have of each medication. &lt;br /&gt;
**You should try to do an inventory of all the medicines you have at least once a year, preferably every six months.&amp;lt;ref&amp;gt;http://www.youthconnectionscoalition.org/content/wp-content/uploads/2015/04/safe_storage.pdf&amp;lt;/ref&amp;gt;   &lt;br /&gt;
*Medications whose labels specify that refrigeration is necessary should always be kept in the refrigerator. &lt;br /&gt;
*The medicine cabinet in a bathroom is often not the best place to store prescriptions. They should be stored in a cool dry place. Humidity, heat, and the change in temperatures in the bathroom can alter the potency of some medications.&amp;lt;ref&amp;gt;http://www.youthconnectionscoalition.org/content/reduce-rx-abuse-2/the-proper-storage-of-prescription-drugs/&amp;lt;/ref&amp;gt;&amp;amp;nbsp;Some storage devices, such as iKeyp, can help protect medications from humidity, even if stored in bathrooms. &lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Improve_Safe_Storage_of_Prescription_Drugs|TR - Increase Safe Storage of Prescription Drugs]]&lt;br /&gt;
&lt;br /&gt;
= Actions to Take =&lt;br /&gt;
&lt;br /&gt;
[[PA_-_Improve_Safe_Storage_of_Prescription_Drugs|Potential Actions and Partners]]&lt;br /&gt;
&lt;br /&gt;
Actions for Individuals&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:Pages with broken file links]] [[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Prescription_Drug_Take-back_%26_Disposal_Program&amp;diff=19862</id>
		<title>Expand Prescription Drug Take-back &amp; Disposal Program</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Prescription_Drug_Take-back_%26_Disposal_Program&amp;diff=19862"/>
				<updated>2020-04-07T22:01:26Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
''Return to [[ZOOM_MAP_-_Reduce_Diversion_of_Prescription_Drugs|Reduce Diversion of Prescription Drugs]]''&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
Most opioid abuse prevention strategies include some sort of prescription drug take-back or disposal program.&amp;amp;nbsp; This is a step in the right direction, but most communities have significant opportunities to expand and enhance these efforts to reach more people and reduce the ability of people to misuse these medications or give them to others who may misuse them.&amp;amp;nbsp; This objective focuses on practical ways to make improvements to existing efforts and to add new options that communities may not yet be doing.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
== Why Safe Disposal is Important ==&lt;br /&gt;
&lt;br /&gt;
'''Intentional Misuse''':&lt;br /&gt;
&lt;br /&gt;
*A majority of abused prescription drugs are obtained from family and friends, including from the home medicine cabinet.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[2]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*SAMHSA’s 2009 National Survey on Drug Use and Health found that over 70 percent of people who used prescription pain relievers non-medically got them from friends or relatives, while approximately 5 percent got them from a drug dealer or from the Internet. &lt;br /&gt;
*Getting hooked on prescription opioids is directly responsible for over 60% of subsequent heroin addictions as addicts turn to this less expensive alternative. &lt;br /&gt;
*Prescription drugs involved in overdoses are almost all originally prescribed by physicians but were used by others who were not prescribed those drugs. (Get sources for this.)&amp;amp;nbsp; &lt;br /&gt;
&lt;br /&gt;
'''Accidental Exposure''':&lt;br /&gt;
&lt;br /&gt;
*When medicines are no longer needed or have expired, it is important to properly dispose of them to reduce harm from accidental exposure or intentional misuse.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[1]&amp;lt;/sup&amp;gt; Throwing drugs in the garbage also is a bad idea, because they can accidentally be taken by kids or pets. &lt;br /&gt;
&lt;br /&gt;
'''Environmental Concerns''':&lt;br /&gt;
&lt;br /&gt;
*Some people propose flushing or pouring unused medications down the drain, however medications flushed into the waste stream can end up in water supplies.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[3]&amp;lt;/sup&amp;gt; &lt;br /&gt;
*Since the drugs in take-back programs are incinerated, take-back programs are the safest way to get rid of the chemicals and to stop them from getting into drinking water and watersheds as well as in the hands of those at risk. &lt;br /&gt;
*Innovative mail-back options provide a convenient way for people to have excess medications disposed of through incineration. (Details further down on this page.) &lt;br /&gt;
&lt;br /&gt;
== Costs and Benefits of Safe Disposal Options ==&lt;br /&gt;
&lt;br /&gt;
This fact sheet from the Product Stewardship Institute provides a good summary of the costs and benefits of different drug take-back and disposal options.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
[https://cdn.ymaws.com/www.productstewardship.us/resource/resmgr/gotoguide/drug_take-back_costs_fact_sh.pdf https://cdn.ymaws.com/www.productstewardship.us/resource/resmgr/gotoguide/drug_take-back_costs_fact_sh.pdf]&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
== To Flush or Not to Flush ==&lt;br /&gt;
&lt;br /&gt;
If no take-back programs are readily available, it is still important to dispose of the medications quickly and appropriately. Some prescriptions include instructions on how to dispose of the drug.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[5]&amp;lt;/sup&amp;gt; The [https://www.fda.gov U.S. Food &amp;amp; Drug Administration (FDA)] provides the safest ways of disposing of these medications at home [http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm here]. The FDA also recommends that certain drugs be flushed immediately such as fentanyl patches, Oxycontin, and Percocet. A full list can be found on [http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm#Flush_List this ]page.&amp;amp;nbsp; Others experts strongly recommend &amp;lt;u&amp;gt;'''not'''&amp;lt;/u&amp;gt; flushing medications down the toilet.&amp;lt;ref&amp;gt;Minnesota Pollution Control Agency https://www.pca.state.mn.us/featured/dont-flush-medicines-down-drain&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The bottom line is that the best options are bringing your medications to a take-back day, putting them into a drug disposal kiosk, or using a mail-based program to send in the medications for proper disposal.&amp;amp;nbsp; But, if you don't have access to these options, flushing unused medications that are on the &amp;quot;flush list&amp;quot; is better than keeping them around.&amp;amp;nbsp;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= Special Populations =&lt;br /&gt;
&lt;br /&gt;
== Senior Citizens ==&lt;br /&gt;
&lt;br /&gt;
Senior citizens have a disproportionate number of medications in their homes. Helping seniors understand how to properly dispose of medications can make a big difference in the success of your program.&amp;amp;nbsp; The Colorado Consortium for Prescription Drug Abuse Prevention has developed a successful program for reachng people age 65+ called &amp;quot;You're the Solution.&amp;quot; This campaign has techniques and materials that can be used around the country.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
Learn more about [[You're_the_Solution|You're_the_Solution]]&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== Nursing Homes ==&lt;br /&gt;
&lt;br /&gt;
Individual patients aside, one study estimated the nation’s nursing homes discard anywhere from $73 million to $378 million worth of drugs a year. Some are incinerated, but many are flushed.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[6]&amp;amp;nbsp; &amp;amp;nbsp;&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Nursing homes could be provided with information and tools (or services) for more appropriate disposal options that are better for the environemnt and that minimize the likelihood of diversion of these medications.&lt;br /&gt;
&lt;br /&gt;
== Hospice Programs or Funeral Home Programs ==&lt;br /&gt;
&lt;br /&gt;
Hospice programs can help family members understand how to properly handle the medications they inherit when a loved one passes away.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[7]&amp;lt;/sup&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Funeral Homes may pass out a brochure to remind people to make sure that any prescription drugs that were being taken by a loved one are properly disposed of.&amp;amp;nbsp; People in the late stages of life may have been getting prescription opioids to deal with pain.&amp;amp;nbsp; Hospice and funeral homes could be provided with disposal products (like Seal&amp;amp;Send envelopes)&lt;br /&gt;
&lt;br /&gt;
= Take-back Events =&lt;br /&gt;
&lt;br /&gt;
== DEA National Drug Take-Back Day Initiative ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;The National Prescription Drug Take Back Day Initiative addresses a crucial public safety and public health issue by providing an opportunity for Americans to prevent drug addiction and overdose deaths. As of May 2017, the DEA has promoted 13 national take-back days and they continue to collect more and more drugs each time. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[8]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;'''[https://www.deadiversion.usdoj.gov/drug_disposal/takeback/newsrelease.htm Program Successes]'''&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Over 4,200 law enforcement and community partners and 5,500 sites across the country.&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Since September 2010, these events have altogether collected 8,103,363 pounds (4,052 tons) of prescription drugs.&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;The last National Take-back Day collected more than 900,386 pounds (450 tons).&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;To promote your local Rx Take Back Day, the DEA provides a [https://www.dea.gov/take-back/takeback-day_2016_oct.html partnership toolkit] featuring promotional materials for associated partners.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[9]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;font-size: 15.6px&amp;quot;&amp;gt;See [[TR_-_Expand_Prescription_Drug_Take-back_&amp;amp;_Disposal_Programs|Tools &amp;amp; Resources]] for more DEA take-back resources and other ideas on how to implement a local take-back day.&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;State Level Drug Take Back Programs&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;See below for inspiration and ideas to replicate from current state efforts:&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.ddap.pa.gov/Prevention/Pages/Drug_Take_Back.aspx#.V07YY_krLcs Pennsylvania]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.in.gov/bitterpill/ Indiana]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.oregon.gov/oha/ph/HealthyEnvironments/DrinkingWater/SourceWater/Pages/takeback.aspx Oregon]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.artakeback.org/index.html Arkansas]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.takebackyourmeds.org/ Washington]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://stoprxabuseinga.org/ Georgia]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Local Disposal Drop Boxes&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; =&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
== &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Finding Disposal Locations&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
=== &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Medication Disposal Locators&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Use the following links to find drug disposal locations&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://apps.deadiversion.usdoj.gov/pubdispsearch/spring/main?execution=e1s1 DEA's Disposal Locator] - Find locations in your ZIP code. These collectors are registered with the DEA and pass unused medicine on to the agency to disposed.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[10]&amp;lt;/sup&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://rxdrugdropbox.org/ Rx Drop Box]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://disposemymeds.org/ Dispose My Meds]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://nabp.pharmacy/initiatives/awarxe/drug-disposal-locator/ National Association of Boards of Pharmacy]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.americanmedicinechest.com/ The American Medicine Chest Challenge]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://walgreens.maps.arcgis.com/apps/MapSeries/index.html?appid=53cf1b54abf34c4bacdec863e5c56391 Walgreens Safe Medication Disposal Program]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
== &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Increasing the Number of Drug Drop-Boxes in your Community&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
Since disposing of unneeded medications via a drug drop box is considered the best option, it is important for communities to increase the number of drop boxes that are available and to promote awareness of those drop boxes.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
Ths [https://cdn.ymaws.com/www.productstewardship.us/resource/resmgr/pharms_reports_factsheets/160920_PSI_Pharmacy_Guide_vS.pdf How-To Guide for Drug Take-Back] , created by the Product Stewardship Institute, provides detailed guidance for expanding and improving a pharmacy-based collection program.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;The [http://www.rxdrugdropbox.org/ NADDI prescription drug dropbox ] website is an important resource to find locations of drop boxes, buy boxes, apply for grants, and other information about drop boxes.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;With the help of the of the [https://www.naddi.org/ National Association of Drug Diversion Investigators], communities can apply for grants to receive a drop box that will hold old opioids to prevent abuse. These boxes have resulted in multiple cities and communities to be safer, and reduce the risk of opioid addiction. Boxes are to be located in close proximity to law enforcement agencies so nothing happens to them. Multiple boxes have been placed in the State of Minnesota, and after reaching out to one town in specific, Fridley&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[11]&amp;lt;/sup&amp;gt; , they told us that they have seen a positive response to the drop-box. They have discarded pounds of prescription opioids that came from an at-risk community.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;In-Home Disposal&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Medication Mail-back Envelopes&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Stericycle Prescription Drug Seal&amp;amp;Send Pouches&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
Stericyle provides an option for unsed prescription drugs to be mailed to them in an unmarked mailing pouch, and then the pills are incinerated.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Learn more at:&amp;amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;[https://www.stericycleenvironmental.com/service/pharmaceutical-takeback/ https://www.stericycleenvironmental.com/service/pharmaceutical-takeback/]&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
== In-home disposal pouches &amp;amp; powders ==&lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Deterra Drug Disposal System&amp;amp;nbsp;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Minneapolis based company Verde Technologies has created a product called [http://deterrasystem.com/ Deterra®] System which deactivates prescription drugs.&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Each patented Deterra® pouch contains a water-soluble inner pod containing MAT12® activated carbon. Once the pharmaceuticals are placed in the pouch, warm water is then added, which dissolves the inner pod releasing the activated carbon. The warm water also dissolves prescription pills, patches and liquids, allowing them to be adsorbed by the carbon, rendering them inert and non-retrievable.&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;For more information on how to use Deterra®, view this [https://www.youtube.com/watch?v=lSBwBqpTk2c How-to video]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Current Efforts to Promote In-Home Disposal&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Case Studies&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;The state of Pennsylvania has a goal of distributing Deterra® Drug Deactivation and Disposal pouches alongside 10% of all opioid prescriptions.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Attorney General Shapiro Unveils Plan to Distribute 300,000 Drug Disposal Pouches in 12 counties[5]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;objectEmbed&amp;quot;&amp;gt;[https://www.pennlive.com/news/2017/07/drug_deactivation_and_disposal.html https://www.pennlive.com/news/2017/07/drug_deactivation_and_disposal.html]&amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Inspira Health Network (New Jersey) distributed the Deterra® pouch throughout their network.&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.njtvonline.org/news/video/inspira-health-network-battles-opioid-crisis-proper-drug-disposal/ Case Study]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; These pouches render opioids ineffective for misuse and safe for disposal and the environment, are another cost-efficient way to safely dispose of opioids.&lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Benefits&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Inexpensive - Costs $7 per pouch&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Can encourage people to connect with law enforcement - People can pick up free (if already given to law enforcement) pouches from station and dispose of them at home and save any potential embarrassment&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Improve overall water quality - with the majority of people flushing unused medication down the toilet, only water treatment facilities remove less than half of the prescription drugs found in sewage&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;DisposeRx&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;'''&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://disposerx.com/ Dispose Rx] is &amp;quot;a patented (pending) blend of solidifying materials that provides a solution for the safe disposal of unwanted or expired prescription drugs. Dedicated to environmentally friendly and safe non-toxic disposal solutions, DisposeRx is spearheading programs of educating communities with practical and safe medication disposing solutions, thus preventing the cycle of environmental pollution, addiction, overdose, and death.&amp;quot; Prescription drugs can be rendered safe for disposal (and impossible to misuse) by adding powder from a packet directly into the pill bottle and shaking the bottle.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Inexpensive - Costs about $1.50 per packet (and [https://www.aarp.org/health/drugs-supplements/info-2018/walmart-dispose-painkillers-fd.html Walmart gives the packets away free with a prescription or possibly a request])&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Packets can attached to prescriptions with a rubber band (much like flower fertilizer is attached to fresh-cut flowers)&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
*&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Well-suited to campaigns with community partners (like clinics, churches, barbershops or hair salons) to increase distribution to diverse populations.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;See [[TR_-_Expand_Prescription_Drug_Take-back_&amp;amp;_Disposal_Programs|Tools &amp;amp; Resources]] for more information.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Funding for Drug Takeback &amp;amp; Disposal&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Legislation &amp;amp; Drug Companies&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Currently several West Coast counties, the city of San Francisco and the state of Massachusetts have issued legislature that require drug companies to fund drug take-back programs.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[13]&amp;lt;/sup&amp;gt; On a national level, however, only 2.5 percent of eligible take-back organizations are participating, according to the Government Accountability Office. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[14]&amp;lt;/sup&amp;gt; The primary barrier seems to be financial: Maintaining the safe-like prescription drop-off container, training staff to follow the relevant regulations, and destroying the returned medication costs money. As a potential solution, writing policy that mandates opioid manufacturers to pay patients for their returned bottles of pills, along with subsidizing drop off location operators, could offset the costs and be what is needed to make returning leftover medication an automatic habit for consumers. &amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[15]&amp;lt;/sup&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;The [http://www.productstewardship.us/ Product Stewardship Institute], a nonprofit that supports drug take-back programs, calculated that at least a dozen other local governments around the country are considering similar legislation, including several California counties.&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;In Minnesota, pharmaceutical company [http://www.mallinckrodt.com/ Mallinckrodt] donated 30,000 disposal pouch systems to be distributed.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[16]&amp;lt;/sup&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== State Legislation Requiring Disposal Kits be Given with Prescriptions ==&lt;br /&gt;
&lt;br /&gt;
The Kentucky State Senate passed in March 2018 a bill that requires opioids and other abused drugs to be dispensed along with a method to permanently sequester and dispose of any leftover pills. If passed by the house and signed, it will be the first state passing such a bill.&amp;lt;sup class=&amp;quot;reference&amp;quot;&amp;gt;[4]&amp;amp;nbsp;&amp;amp;nbsp;&amp;lt;/sup&amp;gt;[http://www.disposerx.com DisposeRx] will be a popular choice to be given out along with prescription.&amp;amp;nbsp; Other options include the Seal &amp;amp; Send mail-back packages or other options described below.&lt;br /&gt;
&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Tools &amp;amp; Resources&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[[TR_-_Expand_Prescription_Drug_Take-back_&amp;amp;_Disposal_Programs|TR - Expand Prescription Drug Take-back &amp;amp; Disposal Programs]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Actions to Take&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;There are many actions that can be taken by coalitions, organizations or individuals to improve drug take-back and disposal.&amp;amp;nbsp; Explore the ideas via the following link:&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[[PA_-_Expand_Prescription_Drug_Take-back_&amp;amp;_Disposal_Program|Potential Actions for Coalitions]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[PAI_-_Expand_Prescription_Drug_Take-back_&amp;amp;_Disposal_Program|&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Potential Actions for Individuals&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;]]&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;'''Reviewer'''&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
| &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;'''Date'''&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
| &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;'''Comments'''&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;Sources&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
#[http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm [1]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/ http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/ [2]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[http://www.takebackyourmeds.org/what-you-can-do/medicine-disposal-myths-and-facts/ http://www.takebackyourmeds.org/what-you-can-do/medicine-disposal-myths-and-facts/]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.takebackyourmeds.org/what-you-can-do/medicine-disposal-myths-and-facts [3]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://disposerx.com/dl/Kentucky_Press_3-15_final.pdf [4]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[https://www.fda.gov/drugs/safe-disposal-medicines/disposal-unused-medicines-what-you-should-know https://www.fda.gov/drugs/safe-disposal-medicines/disposal-unused-medicines-what-you-should-know]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/EnsuringSafeUseofMedicine/SafeDisposalofMedicines/ucm186187.htm [5]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[http://www.nbcnews.com/id/3077015/ns/health-health_care/t/got-old-medicine-dont-flush-it/#.XXVl6ehKhPZ http://www.nbcnews.com/id/3077015/ns/health-health_care/t/got-old-medicine-dont-flush-it/#.XXVl6ehKhPZ]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.nbcnews.com/id/3077015/ns/health-health_care/t/got-old-medicine-dont-flush-it/#.WmEKDd-nGUk [6]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[https://www.dea.gov/press-releases/2017/05/08/dea-brings-record-amount-unused-prescription-drugs-national-prescription https://www.dea.gov/press-releases/2017/05/08/dea-brings-record-amount-unused-prescription-drugs-national-prescription]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://www.dea.gov/divisions/hq/2017/hq050817a.shtml [7]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[https://www.dea.gov/press-releases/2015/10/01/deas-prescription-drug-take-back-effort-big-success-0 https://www.dea.gov/press-releases/2015/10/01/deas-prescription-drug-take-back-effort-big-success-0]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://www.dea.gov/divisions/hq/2015/hq100115.shtml [8]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[https://www.dea.gov/press-releases/2015/10/01/deas-prescription-drug-take-back-effort-big-success-0 https://www.dea.gov/press-releases/2015/10/01/deas-prescription-drug-take-back-effort-big-success-0]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm101653.htm [9]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[https://www.hometownsource.com/sun_focus/news/local/drop-off-prescription-drugs-anonymously-at-fridley-pd/article_b07bd27d-1122-55fa-8465-f47ad9a861dc.html https://www.hometownsource.com/sun_focus/news/local/drop-off-prescription-drugs-anonymously-at-fridley-pd/article_b07bd27d-1122-55fa-8465-f47ad9a861dc.html]&amp;amp;nbsp;&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://focus.mnsun.com/2013/02/19/drop-off-prescription-drugs-anonymously-at-fridley-pd/ [10]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
#[http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/ http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/ [11]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;​ &lt;br /&gt;
#[https://fortune.com/2016/04/30/big-pharma-drug-take-back/ https://fortune.com/2016/04/30/big-pharma-drug-take-back/]&amp;amp;nbsp;​&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[http://fortune.com/2016/04/30/big-pharma-drug-take-back/ [12]]&amp;lt;/span&amp;gt; &lt;br /&gt;
#[https://www.washingtonpost.com/news/wonk/wp/2017/12/05/one-idea-for-preventing-leftover-opioids-from-fueling-opioid-abuse/ https://www.washingtonpost.com/news/wonk/wp/2017/12/05/one-idea-for-preventing-leftover-opioids-from-fueling-opioid-abuse/]&amp;amp;nbsp;&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://www.washingtonpost.com/news/wonk/wp/2017/12/05/one-idea-for-preventing-leftover-opioids-from-fueling-opioid-abuse/?utm_term=.e9ccd1f56650 [13]]&amp;lt;/span&amp;gt; &lt;br /&gt;
#[https://www.washingtonpost.com/news/wonk/wp/2017/12/05/one-idea-for-preventing-leftover-opioids-from-fueling-opioid-abuse/ https://www.washingtonpost.com/news/wonk/wp/2017/12/05/one-idea-for-preventing-leftover-opioids-from-fueling-opioid-abuse/]&amp;lt;span style=&amp;quot;background-color: #ffffff&amp;quot;&amp;gt;[https://www.washingtonpost.com/news/wonk/wp/2017/12/05/one-idea-for-preventing-leftover-opioids-from-fueling-opioid-abuse/?utm_term=.e9ccd1f56650 [14]]&amp;lt;/span&amp;gt; &lt;br /&gt;
#[http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/ http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/]&amp;amp;nbsp;[http://www.startribune.com/30-000-opioid-deactivation-pouches-being-distributed-in-state/394659601/ [15]] &lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
&amp;amp;nbsp; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:Pages with broken file links]] [[Category:SAFE-Prescriptions and Medical Response]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Reduce_the_Diversion_of_Prescription_Drugs&amp;diff=19861</id>
		<title>Reduce the Diversion of Prescription Drugs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Reduce_the_Diversion_of_Prescription_Drugs&amp;diff=19861"/>
				<updated>2020-04-07T21:59:24Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Top-Level Strategy Map]]&amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp;or&amp;amp;nbsp; &amp;amp;nbsp; Return to [[ZOOM_MAP_-_Reduce_Diversion_of_Prescription_Drugs|Zoom Map - Reduce Diversion of Prescription Drugs]]&lt;br /&gt;
&lt;br /&gt;
Most misuse of prescription drugs is not being done by the peopte who were prescribed the drugs by the doctors.&amp;amp;nbsp; Therefore a core strategy for responding to the opioid crisis must include multiple ways to reduce the diversion of prescription drugs to people who are misusing them.&amp;amp;nbsp; The details for the strategies to address this are in the supporting objectives rather than at this objective.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&amp;lt;div class=&amp;quot;_&amp;quot; style=&amp;quot;color: rgb(51, 51, 51); font-family: sans-serif,arial,verdana,&amp;amp;quot;trebuchet ms&amp;amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;&amp;quot;&amp;gt;The Drug Enforcement Administration (DEA) has estimated that prescription drug diversion is a $25 billion-a-year industry, and that diversion can occur along all points in the drug delivery process, from the original manufacturing site to the wholesale distributor, the physician's office, the retail pharmacy, or the patient.&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879025/&amp;lt;/ref&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot; style=&amp;quot;color: rgb(51, 51, 51); font-family: sans-serif,arial,verdana,&amp;amp;quot;trebuchet ms&amp;amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;&amp;quot;&amp;gt;One study emphasizes the impact of &amp;quot;pill brokers&amp;quot; to the drug diversion market. Pill brokers are people who routinely work with elderly patients and engage in Medicare and Medicaid fraud.&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879025/&amp;lt;/ref&amp;gt;&amp;lt;br/&amp;gt; Rates averaged across 2011 and 2012 show that more than one half of the nonmedical users of pain relievers, tranquilizers, stimulants, and sedatives aged 12 or older got the prescription drugs they most recently use 'from a friend or relative for free.' About 4 in 5 of these nonmedical users who obtained prescription drugs from a friend or relative for free indicated that their friend or relative had obtained the drugs from one doctor.&amp;quot;&amp;lt;ref&amp;gt;http://www.drugwarfacts.org/chapter/diversion&amp;lt;/ref&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot; style=&amp;quot;color: rgb(51, 51, 51); font-family: sans-serif,arial,verdana,&amp;amp;quot;trebuchet ms&amp;amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;&amp;quot;&amp;gt;Violent and property crime associated with controlled prescription drugs (CPD) diversion and abuse has increased in all regions of the United States over the past 5 years, according to the National Drug Intelligence Center and the National Drug Threat Survey. The estimated cost of CPD diversion and abuse to public and private medical insurers isP $72.5 billion a year, much of which is passed to consumers through higher health insurance premiums.&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot; style=&amp;quot;color: rgb(51, 51, 51); font-family: sans-serif,arial,verdana,&amp;amp;quot;trebuchet ms&amp;amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;&amp;quot;&amp;gt;[[Expand_&amp;amp;_Enhance_Prescription_Drug_Monitoring_Program|States with PDMPs]] have realized benefits in their efforts to reduce drug diversion. These include improving the timeliness of law enforcement and regulatory investigations. For example, Kentucky's state drug control investigators took an average of 156 days to complete the investigation of an alleged doctor shopper prior to the implementation of the state's PDMP. The average investigation time dropped to 16 days after the program was established.&amp;lt;ref&amp;gt;http://www.drugwarfacts.org/chapter/diversion&amp;lt;/ref&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div class=&amp;quot;_&amp;quot; style=&amp;quot;color: rgb(51, 51, 51); font-family: sans-serif,arial,verdana,&amp;amp;quot;trebuchet ms&amp;amp;quot;; font-size: 13px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;&amp;quot;&amp;gt;&lt;br /&gt;
= Bottle Tracking =&lt;br /&gt;
&lt;br /&gt;
=== &amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;National Association of Drug Diversion Investigators&amp;lt;/span&amp;gt; ===&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;In recent studies &amp;lt;ref&amp;gt;https://www.phmic.com/wp-content/uploads/2016/07/PMC_CrimeReport.pdf&amp;lt;/ref&amp;gt;, it has been shown that armed robberies in pharmacies has increased from 69.4 per month to 76.2 per month. These two rates come from comparing crime rate data from January- June, 2015 and January- June, 2016. A possible aid to this, presented by the NADDI, is to incorporate technology onto medication bottles to show where these bottles were to go in the presence of a robbery.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;In the event of a robbery, NADDI, proposes that giving out fake prescription bottles that have a tracking device inside of them. Police would be notified immediately and would allow them to reach the perpetrators and deal with them accordingly. This will help communities in two ways; allowing help to be given to people who have the need to rob pharmacies and lessen the amount of money lost via robberies that occur. The NADDI website has multiple tools and sources for any community interested, via [http://naddibottletracking.org/about-the-program/ this link.] This hub will give ways to initiate the plan and will help lead to a better, safer community.&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;[http://naddibottletracking.org/law-enforcement/ NADDI: Bottle Tracking]&amp;lt;/span&amp;gt;&amp;lt;span class=&amp;quot;reference&amp;quot; style=&amp;quot;background-color: rgb(255, 255, 255); font-size: 9.75px; vertical-align: baseline;&amp;quot;&amp;gt;[[Reduce_Access_to_Opioids#cite_note-2|[2]]]&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= &amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Example Programs&amp;lt;/span&amp;gt; =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Mayo Clinic&amp;lt;/span&amp;gt;'''&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;The Mayo Clinic developed a new position called the Medication Diversion Prevention Coordinator (MDPC) within the Department of Pharmacy within their larger facilities. This position requires someone familiar with the Controlled Substance supply chain and management policies who is, therefore, able to assess areas of vulnerability for potential diversion.&amp;lt;ref&amp;gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538481/&amp;lt;/ref&amp;gt; Through multiple individuals who held this position, a &amp;quot;best practices&amp;quot; list was created that identified 77 specific points that, were all the points implemented, would create what is believed to be the best possible system to date to prevent controlled substances diversion.&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;At larger Mayo Clinic Facilities, teams have been created to investigate suspected diversion episodes. These multidisciplinary teams, all subgroups of the Medication Diversion Prevention Committees, are called the drug diversion response teams (DDiRT). Each team consists of the MDPC, the Director of Pharmacy, a member of the Department of Safety and Security, and a physician chair of the Medication Diversion Prevention Committee. When diversion is suspected, any Mayo Clinic employee can initiate the chain of events that results in a thorough investigation. If there is concern that the diversion might involve an acutely impaired or intoxicated HCW, his or her supervisor is engaged and the HCW is immediately, but discreetly, removed from patient care duties and escorted to a new location for further evaluation including a &amp;quot;for cause&amp;quot; drug test.&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
== Main Pathways for Prescription Drug Diversion ==&lt;br /&gt;
&lt;br /&gt;
Major ways that prescription drugs are diverted to uses other than the intended use of the prescription include:&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
*People giving pills to a friend or relative &lt;br /&gt;
*People stealing pills (from friends/relatives or strangers) &lt;br /&gt;
*People buying pills from someone who was prescribed the pills or from someone who stole them. &lt;br /&gt;
*People stealing pills from a pharmacy or healthcare provider &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools and&amp;amp;nbsp;Resources =&lt;br /&gt;
&lt;br /&gt;
Details for Tools and Resources are on the more detailed&amp;amp;nbsp;objectives on Zoom Strategy Map for this topic.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Reduce_the_Diversion_of_Prescription_Drugs&amp;diff=19857</id>
		<title>Reduce the Diversion of Prescription Drugs</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Reduce_the_Diversion_of_Prescription_Drugs&amp;diff=19857"/>
				<updated>2020-04-07T21:47:07Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Top-Level Strategy Map]]&amp;amp;nbsp; &amp;amp;nbsp; &amp;amp;nbsp;or&amp;amp;nbsp; &amp;amp;nbsp; Return to [[ZOOM_MAP_-_Reduce_Diversion_of_Prescription_Drugs|Zoom Map - Reduce Diversion of Prescription Drugs]]&lt;br /&gt;
&lt;br /&gt;
Most misuse of prescription drugs is not being done by the peopte who were prescribed the drugs by the doctors.&amp;amp;nbsp; Therefore a core strategy for responding to the opioid crisis must include multiple ways to reduce the diversion of prescription drugs to people who are misusing them.&amp;amp;nbsp; The details for the strategies to address this are in the supporting objectives rather than at this objective.&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
== Statistics on Diversion ==&lt;br /&gt;
&lt;br /&gt;
Add statistics here&lt;br /&gt;
&lt;br /&gt;
== Main Pathways for Prescription Drug Diversion ==&lt;br /&gt;
&lt;br /&gt;
Major ways that prescription drugs are diverted to uses other than the intended use of the prescription include:&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
*People giving pills to a friend or relative &lt;br /&gt;
*People stealing pills (from friends/relatives or strangers) &lt;br /&gt;
*People buying pills from someone who was prescribed the pills or from someone who stole them. &lt;br /&gt;
*People stealing pills from a pharmacy or healthcare provider &lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Tools and&amp;amp;nbsp;Resources =&lt;br /&gt;
&lt;br /&gt;
Details for Tools and Resources are on the more detailed&amp;amp;nbsp;objectives on Zoom Strategy Map for this topic.&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Community_Service_Alternatives_to_Incarceration&amp;diff=19837</id>
		<title>Expand Community Service Alternatives to Incarceration</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Expand_Community_Service_Alternatives_to_Incarceration&amp;diff=19837"/>
				<updated>2020-04-06T18:56:47Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;Return to [[ZOOM_MAP_-_Prioritize_SUD_Treatment_Over_Incarceration|Zoom Map - Prioritize SUD Treatment Over Incarceration]] &lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
When people are breaking laws, get arrested and convicted of a crime, having their punishment be in the form of community service can be an alternative to incarceration.&amp;amp;nbsp; This can be less damaging to their lives moving forward than incarceration.&amp;amp;nbsp; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Background =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Alternative to incarceration is any punishment given to an individual who commits a crime that is served by means outside of confinement in a jail or prison. Alternatives to incarceration have proved to be less expensive than incarceration. Additionally, alternatives can repair harms suffered by victims, provide benefits to the community, treat individuals struggling with SUD, mental illness, or a coexistence of both; and rehabilitate offenders. It is important that before we can maximize the benefits of alternatives to incarceration, however, we must repeal mandatory minimums and give courts the power to use cost-effective, recidivism-reducing sentencing options instead.&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Pros of Alternatives to Incarceration =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Give Courts More Sentencing Options&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Each offender and crime is unique, and prison or jail time may not always be the most effective response. If courts have options other than incarceration, they can better tailor a cost-effective sentence that fits the offender and the crime, protects the public, and provides rehabilitation.&amp;lt;ref name=&amp;quot;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;&amp;lt;u&amp;gt;'''Save Taxpayer Money'''&amp;lt;/u&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;It costs over $28,000 to keep one person in federal prison for one year (some states’ prison costs are much higher).&amp;amp;nbsp; Alternatives to incarceration are cheaper, help prevent prison and jail overcrowding, and save taxpayers millions.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;quot; /&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''S'''&amp;lt;/u&amp;gt;&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;&amp;lt;u&amp;gt;'''trengthen Families and Communities'''&amp;lt;/u&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Prison or jail time separates the offender from his or her spouse and children, sometimes for decades at a time. Alternatives to incarceration keep people with their families, in their neighborhoods and jobs, and allow them to earn money, pay taxes, and contribute to their communities.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;quot; /&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
'''&amp;lt;u&amp;gt;P&amp;lt;/u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;'''&amp;lt;u&amp;gt;rotect the Public by Reducing Crime&amp;lt;/u&amp;gt;'''&amp;amp;nbsp;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Over 40% of all people leaving prison will reoffend and be back in prison within three years of their release. Alternatives to prison such as drug and mental health courts are proven to confront the underlying causes of crime (i.e., drug addiction and mental illness) and help prevent offenders from committing new crimes.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;quot; /&amp;gt;&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;&amp;lt;u&amp;gt;'''The Public Supports Alternatives to Incarceration'''&amp;lt;/u&amp;gt;&amp;amp;nbsp;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Over ~75% of adults believe that alternatives to incarceration (probation, restitution, community service, and/or rehabilitative services) are the most appropriate sentence for nonviolent, non-serious offenders and that prison or jail are appropriate only if these alternatives fail.&amp;lt;/font&amp;gt;&amp;lt;ref name=&amp;quot;https://famm.org/wp-content/uploads/FS-Alternatives-in-a-Nutshell.pdf&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Incarceration Alternatives =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Some argue that alternative to incarceration is a lesser sentence without impact. But studies have shown that the vast majority of survivors also prefer investments in education, mental health treatment, drug treatment, and job training to more spending on prisons and jails.&amp;lt;ref name=&amp;quot;https://www.nidirect.gov.uk/articles/non-custodial-sentences&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Various Alternative Sentences as Alternative to Incarceration&amp;lt;/font&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Monetary Fine&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;A fine is the most common form of punishment given by the courts. The offender must pay a fixed sum of money. If they don't pay, they could get a prison sentence.&amp;lt;/font&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Probation Order&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*W&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;hen an offender is supervised by a probation officer in the community for a certain time.Sometimes the court will apply additional requirements to the probation order, including:&amp;lt;/font&amp;gt; &lt;br /&gt;
**&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Mandatory attendance of a alcohol or drug rehabilitation center&amp;lt;/font&amp;gt; &lt;br /&gt;
**&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Mandatory attendance of a day center&amp;lt;/font&amp;gt; &lt;br /&gt;
**&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Mandatory attendance of any other medical treatment or counselling&amp;lt;/font&amp;gt;   &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Community Service Order&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;When an offender gets a community service order, they must do unpaid work in the community for a derration that is decided in the discretion of the judge&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;They must work the hours as instructed. If they don't do the work, they will be returned to court, where they could receive a fine or any other sentence&amp;lt;/font&amp;gt; &lt;br /&gt;
*&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;This can be utilized in combination with a probation order&amp;lt;/font&amp;gt; &lt;br /&gt;
&lt;br /&gt;
&amp;lt;u&amp;gt;'''&amp;lt;font style=&amp;quot;background-color:#ffffff&amp;quot;&amp;gt;Conditional or Absolute Discharge&amp;lt;/font&amp;gt;'''&amp;lt;/u&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Expand_Community_Service_Alternatives_to_Incarceration|TR - Expand Community Service Alternatives to Incarceration]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Treatment_and_Recovery_Support_During_Incarceration&amp;diff=19836</id>
		<title>Enhance Treatment and Recovery Support During Incarceration</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Treatment_and_Recovery_Support_During_Incarceration&amp;diff=19836"/>
				<updated>2020-04-06T18:39:28Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users|Zoom Map - (Shift from Punishment to Treatment Approach for Opioid Users)]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Overview =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research has shown that a vast amount of the inmate population, on both the state and federal level, suffer from substance use disorder, a psychological disorder, or a combination of the two. Studies have shown that proper treatment during incarceration that is followed through to post release, significantly lowers their risk for relapse, criminality, inmate misconduct, and recidivism.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Prison Treatment Programs =&lt;br /&gt;
&lt;br /&gt;
The Criminal Justice System has supported treatment during incarceration by offering&amp;amp;nbsp;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;psychotherapy sessions, religious ministry meetings and 12-step programs such as Alcoholics Anonymous to inmates with substance use problems.&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
While there is significant need for more availability, federal prisons offer a number of programs designed to assist inmates in overcominig a substance use disorder such as:&lt;br /&gt;
&lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Drug Abuse Education&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**E&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ntails a series of classes that educate inmates on substance use disorder and the effects it has on your body and mind&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Nonresidential Drug Abuse Treatment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**A&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;12 week CBT (cognitive-behavioral therapy) program that is organized in group sessions&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;This program addresses criminal lifestyles while also giving inmates the opportunity to increase skills in the areas of rational thinking, communication, and institution to community adjustment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Inmates that are enrolled in this program normally have short sentences, do not meet the Residential Drug Abuse Program, are waiting to be enrolled in RDAP, are in transition back into the community or have a positive urinalysis test&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Residential Drug Abuse Program (RDAP)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**T&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;he most intensive program that the Bureau provides&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Inmates in this program live in their own separate community from the rest of the population. Inmates take part in daily half-day programming and half-day of work, school, or vocational activities; this program is normally nine months in length&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research shows inmates that take part in RDAP are less likely to recidivate and relapse to drug use by significant amounts compared to those inmates who do not take part in RDAP&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Community Treatment Services (CTS)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Provides continued care to inmates who have been released and put into Residential Reentry Centers or on Home Confinement&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Evidence shows that the period after being released is the most vulnerable time for inmates to relapse back to drug use or criminal activity; continued treatment after release is vital to the success of the offender completing their treatment&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;   &lt;br /&gt;
&lt;br /&gt;
= Benefits of Successful Prison Treatment Programs =&lt;br /&gt;
&amp;lt;div&amp;gt;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Well-designed prison treatment programs reduce relapse, criminality, inmate misconduct and recidivism — the likelihood that a convicted criminal will reoffend. They also increase levels of education, mend relationships, boost employment opportunities upon release and improve overall health.&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;https://doi.org/10.1007/s11920-013-0414-z&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research shows that residential prison treatment is cost-effective if prisoners continue treatment after their release. The cost of treatment pales in comparison to the cost of incarceration. Rehab helps prisoners overcome drug use and reduces the economic burden of recidivism.&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://doi.org/10.1007/s11920-013-0414-z&amp;quot; /&amp;gt;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Issues Affecting the Availability of Effective Treatment =&lt;br /&gt;
&lt;br /&gt;
== Overcrowding of Jails and Prisons ==&lt;br /&gt;
&lt;br /&gt;
O&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;vercrowding of jails and prisons is a leading factor as to why inmates with drug dependency problems are not enrolled in these programs. The overcrowding of jails leads to an increase in the length of the waiting lists to enter drug treatment programs. In addition to overcrowding, staff shortages and limited resources are part of the issue of low enrollment in drug treatment programs.&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Need for Trauma-Informed Care ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Incarcerated prisoners are marked by considerable diversity, yet they share a common experience of incarceration. Prisons can be violent, harsh, psychologically damaging environments; incarcerated people live in an environment that is both depersonalizing and dehumanizing. Moreover, the social stigma associated with incarceration, combined with the depersonalizing effects of imprisonment, may result in a sense of hopelessness and powerlessness, as well as deeply internalized shame and guilt. Thus, in addition to treating substance abuse and other mental disorders, the consensus panel recommends that in-prison treatment also address the trauma of the incarceration itself as well as a prison culture that conflicts with treatment goals.&amp;lt;ref name=&amp;quot;https://www.ncbi.nlm.nih.gov/books/NBK64123/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Training =&lt;br /&gt;
&lt;br /&gt;
 Residential Substance Abuse Training RSAT training and technical assistance tool&lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Treatment_During_Incarceration|TR - Enhance Treatment During Incarceration]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	<entry>
		<id>http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Treatment_and_Recovery_Support_During_Incarceration&amp;diff=19835</id>
		<title>Enhance Treatment and Recovery Support During Incarceration</title>
		<link rel="alternate" type="text/html" href="http://ifi-wikis.com/IFI-OpioidCrisis/index.php?title=Enhance_Treatment_and_Recovery_Support_During_Incarceration&amp;diff=19835"/>
				<updated>2020-04-06T18:38:28Z</updated>
		
		<summary type="html">&lt;p&gt;Dmt7109: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;mw-parser-output&amp;quot;&amp;gt;&amp;lt;div class=&amp;quot;wiki&amp;quot; id=&amp;quot;content_view&amp;quot; style=&amp;quot;display: block&amp;quot;&amp;gt;&lt;br /&gt;
Return to [[Opioid_Top-Level_Strategy_Map|Opioid Top-Level Strategy Map]] or [[ZOOM_MAP_-_Shift_from_Punishment_to_Treatment_Approach_for_Opioid_Users|Zoom Map - (Shift from Punishment to Treatment Approach for Opioid Users)]]&amp;lt;br/&amp;gt; &amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Overview =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research has shown that a vast amount of the inmate population, on both the state and federal level, suffer from substance use disorder, a psychological disorder, or a combination of the two. Studies have shown that proper treatment during incarceration that is followed through to post release, significantly lowers their risk for relapse, criminality, inmate misconduct, and recidivism.&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Prison Treatment Programs =&lt;br /&gt;
&lt;br /&gt;
The Criminal Justice System has supported treatment during incarceration by offering&amp;amp;nbsp;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;psychotherapy sessions, religious ministry meetings and 12-step programs such as Alcoholics Anonymous to inmates with substance use problems.&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
While there is significant need for more availability, federal prisons offer a number of programs designed to assist inmates in overcominig a substance use disorder such as:&lt;br /&gt;
&lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Drug Abuse Education&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**E&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;ntails a series of classes that educate inmates on substance use disorder and the effects it has on your body and mind&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Nonresidential Drug Abuse Treatment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**A&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;12 week CBT (cognitive-behavioral therapy) program that is organized in group sessions&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;This program addresses criminal lifestyles while also giving inmates the opportunity to increase skills in the areas of rational thinking, communication, and institution to community adjustment&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Inmates that are enrolled in this program normally have short sentences, do not meet the Residential Drug Abuse Program, are waiting to be enrolled in RDAP, are in transition back into the community or have a positive urinalysis test&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Residential Drug Abuse Program (RDAP)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**T&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;he most intensive program that the Bureau provides&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Inmates in this program live in their own separate community from the rest of the population. Inmates take part in daily half-day programming and half-day of work, school, or vocational activities; this program is normally nine months in length&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research shows inmates that take part in RDAP are less likely to recidivate and relapse to drug use by significant amounts compared to those inmates who do not take part in RDAP&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;   &lt;br /&gt;
*'''&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Community Treatment Services (CTS)&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;''' &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Provides continued care to inmates who have been released and put into Residential Reentry Centers or on Home Confinement&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt; &lt;br /&gt;
**&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Evidence shows that the period after being released is the most vulnerable time for inmates to relapse back to drug use or criminal activity; continued treatment after release is vital to the success of the offender completing their treatment&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;   &lt;br /&gt;
&lt;br /&gt;
= Benefits of Successful Prison Treatment Programs =&lt;br /&gt;
&amp;lt;div&amp;gt;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Well-designed prison treatment programs reduce relapse, criminality, inmate misconduct and recidivism — the likelihood that a convicted criminal will reoffend. They also increase levels of education, mend relationships, boost employment opportunities upon release and improve overall health.&amp;amp;nbsp;&amp;lt;ref name=&amp;quot;https://doi.org/10.1007/s11920-013-0414-z&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;amp;nbsp;&amp;lt;/div&amp;gt; &amp;lt;div&amp;gt;&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Research shows that residential prison treatment is cost-effective if prisoners continue treatment after their release. The cost of treatment pales in comparison to the cost of incarceration. Rehab helps prisoners overcome drug use and reduces the economic burden of recidivism.&amp;amp;nbsp;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&amp;lt;ref name=&amp;quot;https://doi.org/10.1007/s11920-013-0414-z&amp;quot; /&amp;gt;&amp;lt;/div&amp;gt; &lt;br /&gt;
= Issues Affecting the Availability of Effective Treatment =&lt;br /&gt;
&lt;br /&gt;
== Overcrowding of Jails and Prisons ==&lt;br /&gt;
&lt;br /&gt;
O&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;vercrowding of jails and prisons is a leading factor as to why inmates with drug dependency problems are not enrolled in these programs. The overcrowding of jails leads to an increase in the length of the waiting lists to enter drug treatment programs. In addition to overcrowding, staff shortages and limited resources are part of the issue of low enrollment in drug treatment programs.&amp;lt;ref name=&amp;quot;https://www.alec.org/article/drug-treatment-programs-of-the-federal-bureau-of-prisons-exist-but-need-more-availability/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Need for Trauma-Informed Care ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span style=&amp;quot;font-size:small;&amp;quot;&amp;gt;&amp;lt;font style=&amp;quot;background-color: rgb(255, 255, 255);&amp;quot;&amp;gt;Incarcerated prisoners are marked by considerable diversity, yet they share a common experience of incarceration. Prisons can be violent, harsh, psychologically damaging environments; incarcerated people live in an environment that is both depersonalizing and dehumanizing. Moreover, the social stigma associated with incarceration, combined with the depersonalizing effects of imprisonment, may result in a sense of hopelessness and powerlessness, as well as deeply internalized shame and guilt. Thus, in addition to treating substance abuse and other mental disorders, the consensus panel recommends that in-prison treatment also address the trauma of the incarceration itself as well as a prison culture that conflicts with treatment goals.&amp;lt;ref name=&amp;quot;https://www.ncbi.nlm.nih.gov/books/NBK64123/&amp;quot; /&amp;gt;&amp;lt;/font&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
= Training =&lt;br /&gt;
&lt;br /&gt;
 Residential Substance Abuse Training RSAT training and technical assistance tool&lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
  &lt;br /&gt;
&lt;br /&gt;
= Tools &amp;amp; Resources =&lt;br /&gt;
&lt;br /&gt;
[[TR_-_Enhance_Treatment_During_Incarceration|TR - Enhance Treatment During Incarceration]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br/&amp;gt; &amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;PAGE MANAGER&amp;lt;/span&amp;gt;:''' &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[insert name here]&amp;lt;/span&amp;gt;&amp;lt;br/&amp;gt; &amp;lt;span style=&amp;quot;background-color: #ffffff; color: #222222; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;'''&amp;lt;span style=&amp;quot;color: #4d4d4d&amp;quot;&amp;gt;SUBJECT MATTER EXPERT&amp;lt;/span&amp;gt;''': &amp;lt;/span&amp;gt;&amp;lt;span style=&amp;quot;background-color: #ffffff; color: #ff0000; font-family: arial,sans-serif; font-size: 12.8px&amp;quot;&amp;gt;[fill out table below]&amp;lt;/span&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wiki_table&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| '''Reviewer'''&lt;br /&gt;
| '''Date'''&lt;br /&gt;
| '''Comments'''&lt;br /&gt;
|-&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
| &amp;amp;nbsp;&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
= Sources =&lt;br /&gt;
&amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &amp;lt;/div&amp;gt; &lt;br /&gt;
[[Category:SAFE-Law Enforcement and Criminal Justice]]&lt;/div&gt;</summary>
		<author><name>Dmt7109</name></author>	</entry>

	</feed>